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Swine are the only livestock species that produce a functional protein for both GnRH-II
and GnRHR-II. Our laboratory has reported that this signaling complex and its receptor
(GnRHR-II) facilitate the production of testosterone, independent of stimulation by LH.
To further examine the function of GnRH-II, we developed a line of swine with 70%
reduced GnRHR-II mRNA levels (GnRHR-II KD) compared to control littermates. Mass
spectrometry analysis of circulating steroid hormone concentrations in mature boars
revealed transgenic animals had reduced levels of gonadal steroids than control males.
Paradoxically, mass spectrometry evaluation of testicular tissue indicated no difference
between lines for gonadal steroid hormone levels. To this end, we examined a potential
cause for this discrepancy, sulfoconjugation, which is not typically included in mass
spectrometry steroid analysis. Often overlooked, steroid sulfates play an important role in
steroid homeostasis. Swine produce high concentrations of sulfoconjugates and proteins
associated with this pathway are present within the porcine testis. We designed primers to
be used in ddPCR for two known sulfotransferases (STULT2A1 and SULT1E1) which
perform conjugation, as well as steroid sulfatase (STS), which removes sulfate. Also
included were a rate-limiting enzyme (PAPSS), a sulfate exporter (ABCC1), and a sulfate
importer (OSCP1) as steroid sulfates are hydrophilic and are unable to diffuse across the
cell membrane. These data did not show any significance between GnRHR-II KD (n=13)

and control littermates (n=11; P > 0.05). Although we did not detect any differences in
expression of these genes, this pathway requires more investigation. The importance of
this pathway still offers a potential target of interest to rescue the GnRHR-II KD
phenotype.
Analysis of the testicular transcriptome was performed via RNA sequencing of
mature (>300 d) GnRHR-II KD (n=10) and control (n=7) testes. Read mapping with a
false discovery rate (FDR) adjusted analysis (P≤ 0.05) described 81,209 transcripts of
which we determined the presence of 24 differentially expressed genes (DEGs). Of these,
13 DEGs upregulated in and 11 DEGs were downregulated KD boars. Putative functions
include pathways of spermatogenesis (LOC106504199), cell signaling (GUCY1A3),
mitochondrial function (LOC100524239), transcriptional regulation (PUF60, ZNF33B),
ubiquitination (UBE2W, USP42), and differentiation (EGR1, FIBIN, MSI2). These
informative DEGs provide potential targets for improvement of boar fertility.

To mom, who we lost during the course of this program but is never far from my
thoughts. Love always.
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CHAPTER I

INTRODUCTION
As the demand for meat increases to accommodate the global population crisis
producers are challenged to efficiently fulfill this need (Godfray et al., 2010). Worldwide,
pork accounts for approximately 33% of all meat production, and U.S. pork represents
30% of that market (USDA, 2020). One of the greatest challenges to producers is
reproductive failure (Kraeling et al., 2015). As more than 90% of all swine are produced
via artificial insemination (AI; Knox, 2016), poor quality boars have a great impact on
farrowing rate and litter sizes (Bortolozzo et al., 2015). Yet, boar fertility cannot be
evaluated until sexual maturity is reached (approximately 10 months of age; Kraeling et
al., 2015), by which time boar taint has reduced carcass value and marketability
(Bahelka, et al., 2021). Boar production also limits producers due to their high turnover
cost (>$1,000) and short reproductive lifespans (Althouse, 2007). On average, stud barns
only use boars for a duration of 20 months (Kotesu and Sasaki, 2009) and 18% of all
culled animals are removed due to reproductive inefficiencies (D’Allaire et al., 1992). To
address subfertility in specific boars, semen pooling is commonly used (Maiorano et al.,
2019), which has been shown to improve litter size by 0.6 piglets per litter (Kuo et al.,
2000). However, this adaptation requires increased investment in the maintenance of
extra animals.
In males, reproductive function is regulated by the androgen, testosterone.
Classical testosterone synthesis is regulated by the hypothalamic-pituitary-gonadal (HPG)
axis. Gonadotropin-releasing hormone (GnRH-I) is secreted from the hypothalamus into

2

the hypophyseal portal system where it binds to its receptor (GnRHR-I) on gonadotropes
in the anterior pituitary gland. Receptor binding triggers the synthesis and secretion of the
gonadotropins, follicle stimulating hormone (FSH) and luteinizing hormone (LH) into
circulation. Luteinizing hormone then travels to the testis and binds to its receptor on the
surface of Leydig cells, leading to testosterone secretion. As testosterone is necessary for
sex differentiation, libido, and fertility (Allrich et al., 1982), understanding the
development and function of Leydig cells is critical.
Gonadotropin releasing hormone II (GnRH-II) was originally isolated from the
hypothalamus of chickens (Miyamoto et al., 1984) later renamed GnRH-II, after being
found in the brains of marsupials (King et al., 1989). Since its discovery, GnRH-II has
been identified in every major class of vertebrate (Sherwood et al., 1993) with the
exception of jawless fish (Millar, 2003). While the GnRH-II gene has been isolated in 89
species of mammal (Stewart et al., 2009; Desaulniers et al., 2017), only humans, Old
World monkeys, shrews, and pigs have the appropriate intact coding sequence to produce
a functional ligand (Stewart et al., 2009).
Similar to GnRHR-I, GnRHR-II is a 7-transmembrane, G protein-coupled
receptor (GPCR; Millar et al., 2001) that was originally identified in African catfish
(Tensen et al., 1997; Goos et al., 1997). The gene encoding GnRHR-II is present in no
fewer than 83 mammalian species (Stewart et al., 2009; Millar et al., 2003; Desaulniers et
al., 2017), although the functionality of the gene in these species is questionable. In most
species, the gene contains errors or deletions to the sequence that render it non-functional
such as frameshifts (humans, chimpanzee, cows, dolphin, dog; Cheng and Leung, 2005,
Morgan et al., 2006; Stewart et al., 2009) and premature stop codons (sheep, guinea pig,
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squirrel, cat; Stewart et al., 2009; Morgan et al., 2006; Gault et al., 2004). Only 8 known
species that have an intact gene for production of a functional GnRHR-II (African green
monkey, elephant, kangaroo rat, marmoset, orangutan, pig, rhesus macaque, and tree
shrew; Millar et al., 2003; Stewart et al., 2009). The pig is the only livestock mammal
that has functional genes for both GnRH-II and GnRHR-II, making them a prime
research model to elucidate the biological role of this unique ligand and receptor.
To examine the role that GnRH-II and its receptor play in reproduction, our lab
designed a line of pigs with reduced endogenous levels of GnRHR-II (GnRHR-II KD;
Desaulniers et al., 2017). Hormone profiling of mature GnRHR-II KD boars indicated
82% reduced testosterone concentrations compared to littermate control males, although
LH levels were not different. Mass spectrometry analysis of serum found that levels of all
steroid hormones of testicular origin were reduced in GnRHR-II KD boars but analysis of
testicular extracts had no differences between lines. While we have not ruled out altered
synthesis we identified potential causes for this discrepancy as follows; altered
sulfation/desulfation, cellular transportation, binding proteins, and excretion.
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CHAPTER II
LITERATURE REVIEW
Porcine Leydig cell development and function
Fetal Leydig cells. Porcine Leydig cells develop in three stages, early fetal,
perinatal and pubertal (van Vorstenbosch et al., 1982). Testicular development begins at
approximately 19 days post coitus (DPC) in swine (McCoard et al., 2001), during which
time primordial germ cells (PGC’s) migrate to the primordial ridge and signaling from
bone morphogenetic protein (BMP) triggers differentiation into spermatogonia (Lochab
and Extavour, 2017). At this same time, activation of the sex-determining region of the Y
chromosome (SRY) within pre-Sertoli cells stimulates SRY-Box transcription factor 9
(SOX9) to fully differentiate Sertoli cells by 26 DPC (Yao et al., 2002). Differentiated
Sertoli cells produce anti-Müllerian hormone (AMH), triggering the activation of Desert
Hedgehog (DHH; Racine et al., 1998). Both, in turn, drive differentiation of Leydig cells
from mesenchymal cells (McCarrey and Abbott, 1979) and promote precursor Leydig
cell population growth and testosterone production (Bruhn et al., 1983). Since there is no
differentiation of the hypothalamus or anterior pituitary gland, these fetal Leydig cells are
not dependent on GnRH-I or LH to induce testosterone synthesis (Bruhn et al., 1983). In
point of fact, even decapitated fetuses have typical fetal Leydig cell development (van
Vorstenbosch et al., 1982). At 35 DPC, fetal concentrations of testosterone peak at
approximately 4 ng/ml, but begin to fall rapidly by 40 (1.5 ng/ml) and 50 (0.5ng/ml) DPC
(Ford et al., 1980; Figure 1). These falling concentrations are attributed to Leydig cell
involution of the fetal population (van Vorstenbosch et al., 1982). During this time (~40
DPC), GnRH-I neurons have begun to develop, however, they do not reach the median

5

eminence until around 60 DPC (van Vorstenbosch et al., 1984) and serum LH
concentrations are not detectable until after 80 DPC (Visser and Heyns, 1996).
Perinatal Leydig cells. The second wave of Leydig cell development begins
shortly before parturition, around 95 DPC (Van Straaten and Wensing, 1978). During this
time, mesenchymal cells begin to differentiate into peritubular and intertubular Leydig
cells (Van Straaten and Wensing, 1978), which have increased activity of 3β-HSD
and17β-HSD (van Vorstenbosch et al., 1984). This population of Leydig cells continues
to grow and differentiate after birth until it reaches its peak at approximately 21 days
post-natal (DPN; Van Straaten and Wensing, 1978; Figure 1). A generalized regression
of Leydig cells begins at this time, reaching maximum regression about 35 DPN, when
the differences between the peritubular and intertubular cells begin to disappear (Van
Straaten and Wensing, 1978). Both the intertubular and peritubular Leydig cells shrink in
overall cell volume (Franca et al., 2000) and exhibit only low levels of steroidogenesis
because they lack LH receptors (Avelar et al., 2010).
Pubertal Leydig cells. The final wave of Leydig cell development and
differentiation begins with the onset of puberty. Beginning around 4 months of age
(Reiland, 1978), depending on breed or nutritional status, leptin and insulin stimulate
kisspeptin/neurokinin B/dynorphin A (KNDy) neurons within the arcuate nucleus of the
hypothalamus (Tersawa, 2013). Subsequently, the pulsatile release of kisspeptin triggers
the secretion of GnRH-I from GnRH-I neurons (Chen et al., 2022). During this period,
the number of LH receptors on the surface the Leydig cells increases, making them more
sensitive to LH (McCarrey and Abbott, 1979). Peritubular cells will begin to develop into
clusters of fully differentiated Leydig cells and increase their steroidogenic capacity
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(Lunstra et al., 1986). These cells encompass the majority of the population within the
testicular interstitum, whereas intertubular cells do not undergo any change (van
Vorstenbosch et al., 1984). During puberty, the testicular composition of boars changes
drastically. Along with proliferation of Leydig populations, Sertoli cells begin to grow
and differentiate. These changes are concurrent with a 6-fold increase in total
seminiferous tubule length and increased plasma FSH, driving the proliferation of
spermatogonia (Franca et al., 2000). Continued proliferation of Leydig cells is
accompanied by increased production of testosterone, 17β-estradiol and estrone sulfate
which promote development of accessory sex glands, initiate reproductive behavior, and
induce spermatogenesis (Franca et al., 2000).
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Figure 1. Waves of porcine Leydig cell development occur at three critical time points. Fetal
Leydig cell development beginning ~19 days post coitus (DPC) and peaking at ~35 DPC.
Perinatal Leydig cell population starts to differentiate ~95 DPC and continues through ~35
DPN. Pubertal Leydig cells begin to differentiate from ~120 DPN with full sexual maturity by
300 days of age.
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Steroidogenesis in the boar. Steroidogenesis begins with the cellular
acquisition of cholesterol, the precursor of all steroid hormones. A cell may obtain
cholesterol via several biological means including cellular import, intercellular storage
droplets, or via de novo synthesis. Steroidogenic cells rely primarily on the importation of
lipoproteins either as high-density lipoproteins (HDL) or as low-density lipoproteins
(LDL) from circulation to provide the prerequisite cholesterol. Both HDL and LDL may
be trafficked into a cell for cholesterol acquisition, although by different mechanisms.
Cholesterol bound to HDL enters a cell via scavenger receptor type B Class 1 (SR-B1),
without lipoprotein undergoing endocytosis (Tosheska et al., 2017). LDL-bound
cholesterol undergoes endocytosis and thus, requires extra processing in order to free
cholesterol. Upon LDL-steroid complex binding to a transmembrane LDL receptor, the
tripartite complex will then relocate to an adjacent clathrin-coated pit to begin
endocytosis (Tiwari and Siddiqi, 2012; Figure 2). Following completion of endocytosis,
the clathrin falls away from the vesicle, the receptor is recycled back into the membrane
(Tiwari and Siddiqi, 2012) and sterol transfer proteins shuttle the cholesterol out of the
vesicle (Rone et al., 2009). Cholesterol is then either used for steroidogenesis or esterified
to be stored in intercellular droplets that can be unconjugated by hormone-sensitive lipase
(Hermmerle et al., 2003). If circulating lipoproteins are depleted (Hermmerle et al.,
2003), de novo synthesis of cholesterol from acetate in the endoplasmic reticulum (ER;
Rone et al., 2009) can occur, although
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Figure 2 Cholesterol trafficking and steroidogenesis within porcine Leydig cells.
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this method is energy intensive and generally not the primary source of cellular
cholesterol.
Once free cholesterol has been acquired, it can enter the mitochondria to engage
in steroidogenesis. Movement of cholesterol into the mitochondrial matrix is a two-step
process, although is not fully understood (Elustondo, et al., 2017). Steroid acute
regulatory protein (StAR) is unable to bind cholesterol unless it has been phosphorylated
at Ser195 (Robic and Punier, 2013), which imparts a conformational change to allow
transport of cholesterol one molecule at a time into the intermembrane space (IMS). For
this reason, StAR transport is the rate-limiting step of steroidogenesis. Porcine StAR has
not been entirely characterized, although it is thought to function in much the same way
as other mammalian isoforms since it shares ~87% homology to humans (Robic and
Punier, 2013). Furthermore, there is a positive correlation between levels of StAR and
adipose concentrations of androstenone in mature boars (Grindflek et al., 2010).
The primary site of steroidogenesis is Leydig cells within the testicular
interstitum, for which the boar is noteworthy for having a particularly large interstitum
with a dense Leydig cell population (Miller, 2013), although the adrenal cortex also
produces small quantities of steroid hormones (Turcu and Archus, 2015). The major
steroid in all males is testosterone, which is produced by Δ4 or Δ5 pathways, depending
on the species (rat = Δ4; Browning et al., 1982; human = Δ5; Hammar and
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Figure 3 Classical testosterone synthesis in the porcine Leydig cell. Adapted from
Desaulniers et al., 2017
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Peterson, 2005). Interestingly, pigs are the only characterized species that uses both
pathways (Raeside et al., 2006, Figure 4). Following transport into the IMS, cholesterol
is converted into pregnenolone via enzymatic hydroxylation and cleavage of the 6-carbon
side chain (Clark et al, 1996) by cytochrome P450 family 11 (CYP11A1) with the aid of
two electron-transfer partners, ferredoxin and ferredoxin reductase (Hanukoglu et al.,
1987). Pregnenolone is then shuttled to the ER where it can enter either the Δ4 or Δ5
pathway. Upon entering the Δ5 pathway, it is hydroxylated by CYP17A1 into 17αhydroxypregnenolone, which then undergoes 17,20-lyase conversion with CYP17A1 into
dehydroepiandrosterone (DHEA; Clark et al., 1996; Figure 4). DHEA can then be
dehydrogenated via 3β-hydroxysteroid dehydrogenase (3βHSD) into androstenedione.
Should the Δ4 pathway be utilized, pregnenolone is acted upon first by 3βHSD to form
progesterone and then hydroxylation by CYP17A1 to form 17α-hydroxyprogesterone.
Next, 17α-hydroxyprogesterone is converted into androstenedione by 17,20-lyase
(Miller, 2013; Figure 4). Once either pathway results in androstenedione production,
testosterone is generated via enzymatic action by 17β-hydroxysteroid dehydrogenase
(17βHSD). Another notable enzyme in the steroidogenic pathway is CYP19A1
(aromatase) which catalyzes the conversion of testosterone into 17β-estradiol. Porcine
Leydig cells express high quantities of aromatase (Saez et al., 1989), which accounts for
the remarkable quantity of estrogens produced by the boar testis (Kucera et al., 2019).
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Figure 4 Testosterone production via the Δ4 and Δ5 steroidogenic pathways.
Enzymes: Cytochrome P450 side-chain cleavage (CYP11A1), Cytochrome P450 17αhydroxylase (CYP17A1), 3β-hydroxysteroid dehydrogenase (3β-HSD) and 17βhydroxysteroid dehydrogenase (17β-HSD). Adapted from Colney and Bird, 1997.
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GnRHs and GnRH Receptors
GnRH-I. GnRH-I is a decapeptide (pGlu–His–Trp–Ser–Tyr–Gly–Leu–Arg–Pro–
Gly–NH2; Figure 5) that facilitates the signal from the hypothalamic-pituitary-gonadal
(HPG) axis and plays a vital role in reproduction. GnRH-I is a highly conserved peptide
that has been found in every class of vertebrate that has been examined (Millar, 2005)
represents a 500-million-year evolutionary conservation which indicates a vital biological
function (Tsai and Zhang, 2008). Initially described in porcine hypothalamic extracts by
Dr. Andrew V. Schally, it was considered a novel decapeptide for more than 30 years
(Schally et al., 1971) however, there have since been more than 20 identified variants of
GnRH with no less than 50% sequence homology (Dubois et al., 2002). Furthermore,
among the forms of GnRH, both the N-terminus (pGlu-His-Trp-Ser) and C-terminus
(Pro-Gly NH2) have been conserved which indicate that they are critical to the function of
the ligand (Millar, 2005). Due to the conservation of GnRH-I from fish to humans, it is
believed that it functioned as a form of cell-to-cell communication in the reproduction of
primitive vertebrates (Millar, 2005). Only 3 forms encompass the majority of vertebrates
and only two have been described in mammals (Millar, 2005; Table 1), GnRH-I and
GnRH-II. While there is considerable variation in amino acid sequence, with position 8
being most diverse between isoforms, but this position must be arginine to stimulate
pituitary gonadotropins (Sealfon et al., 1997; Karten and Rivier, 1986).
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Table 1. Structural differences between vertebrate isoforms of GnRH.

a
b

Red amino acids are deviant from classical mammalian GnRH
GnRH-III has never been identified in mammals.
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Figure 5. Structure of GnRH-I. Adapted from Millar, 2005
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Interestingly, it is believed that GnRH-I most likely evolved prior to the pituitary
gland (Millar, 2005) as invertebrate species lacking a pituitary gland also produce the
ligand in their central nervous system. Mammalian GnRH-I is produced by specialized
neurons that originate within the olfactory placode (Wray, 2001) and project into the
median eminence where enzymatically cleaved to form the functional ligand and then
packaged. GnRH-I is secreted into the hypophyseal portal system where it travels to the
anterior pituitary gland. However, the peptide has a relatively short half-life of only 2-4
minutes (Kumar & Sharma, 2014). In the anterior pituitary gland, GnRH-I binds to its
receptor (GnRHR-I) on the surface of gonadotrope cells to facilitate signal transduction
and synthesis of the glycoprotein dimers follicle-stimulating hormone (FSH) and
luteinizing hormone (LH). Activation of gonadotropin synthesis occurs after initiation of
transcription and translation of genes that encode two subunits, a common α-subunit and
a β-subunit (FSHβ or LHβ) which will designate the specificity of the gonadotropin
(Stamatiades and Kaiser, 2018). It has been shown that while LH pulses occur for every
GnRH-I pulse, the responsiveness of FSH appears to behave more constitutively (Pawson
et al., 2008).

GnRHR-I. The receptor for GnRH-I was first described in the mouse in 1992
with descriptions of the receptor functionality in the oocytes of Xenopus being published
the same year (Somoza et al., 2002). GnRHR-I is classified as a 7-transmembrane, Gprotein coupled receptor (7-TMGPCR) and is included in the superfamily of rhodopsinlike GPCRs (Millar, 2005). Structurally speaking, GnRHR is similar to most GPCRs,
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with the NH2-terminal domain followed by the 7α-helix transmembrane domains
containing 3 extracellular and 3 intracellular loops. The 3 extracellular loops are involved
with binding of the ligand and the transmembrane domains are necessary for
conformational changes leading to receptor activation (Millar, 2005). While most GPCRs
possess an intracytoplasmic tail at the carboxyl terminus thought to be involved with
desensitization and internalization of the receptor (Heding et al., 1998), GnRHR-I lacks
this domain (Parrett & McArdle, 2013). Among non-mammalian GnRHRs examined the
highest rates of homology to mammalian receptors is 42-47% (Millar, 2005).
GnRH-I binding to GnRHR-I in gonadotrope cells of the anterior pituitary gland
triggers a signaling cascade wherein Gαq/11 activates phospholipase C (Stojilkovic et al.,
1994) and elevates cytoplasmic calcium and protein kinase C (Kraus et al., 2001). Protein
kinase C activates mitogen activated protein kinases (MAPK) such as extracellular
signal-regulated kinas 1/2, p38, MAPK, extracellular signal-regulated kinase 5, and c-jun
N-terminal kinase (Parrett &McArdle, 2013) which recruit transcription factors (Kraus et
al., 2001). Following the activation of GnRHR, the free Gβγ-subunits promote
phosphorylation of threonine and serine residues in the cytoplasmic domain (Vrecl et al.,
2000) that, in turn, enhance β-arrestin to signal for receptor internalization (Schvartz &
Hazum, 1987; Jean-Charles et al., 2018). Endocytosis then occurs with the formation of a
clatherin-coated pit and the invagination of the cellular membrane, which engulfs the
receptor and removes it from the membrane (De Camilli et al., 1995).
Interestingly, while GnRHR-I undergoes primary activation via Gαq/11there is
evidence that this receptor can employ Gs and Gi signaling as well. Gs signaling relies on
the activation of adenylate cyclase which converts ATP into cyclic AMP (Knollman and
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Conn, 2008). Cyclic AMP will then bind to regulatory subunits of protein kinase A,
which facilitates regulation of protein synthesis and protein phosphorylation. Unlike
Gαq/11 and Gs, Gi functions through inhibitory mechanisms (Birnbaumer, 1992) on
adenylyl cyclase to prevent the formation of cyclic AMP (Kraus et al., 2001).

GnRH- II Gonadotropin releasing hormone II (GnRH-II) was originally
discovered in the hypothalamic tissue of chickens in 1984 (Miyamoto et al., 1984),
GnRH-II was traditionally referred to as chicken GnRH until the identification of the
ligand in other vertebrate species (Millar, 2005). However, GnRH-II is not an isoform of
GnRH-I but is encoded by a separate gene found on chromosome 20 in humans rather
than on human chromosome 8 like GnRH-I (Gaillard et al, 2018) and is found on
chromosome 17 in the pig rather than chromosome 14(Stewart et al., 2009). Structurally,
GnRH-II is a decapeptide but shares only 70% homology with GnRH-I as it differs at
three amino acids (AA) – His5, Trp7, Tyr8 (White et al.,1998; Table 1), and unlike
GnRH-I, GnRH-II contains a preconfigured β-turn and does not require any posttranslational conformation changes in order to interact with its corresponding receptor
(Millar, 2003). Because of this, GnRH-II has been demonstrated to have up to six-fold
higher stability (Siler-Kohder & Grayson, 2001) as well as increased half-life (Licht et
al., 1994), and reduced sensitivity to peptidase degradation (Gault et al., 2003) than that
of GnRH-I which is hypothesized to be the reason for its wide tissue distribution (Pawson
et al., 2003).
GnRH-II has since been identified in all examined vertebrate species (Millar,
2004), with the exception of jawless fish (Millar, 2003), including in more than 80
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mammalian species. The gene sequence encoding GnRH-II remains unchanged over 500million years of evolution (Millar and King, 1987), which indicates a high selective
pressure. However, various mutations (e.g., frame shifts and premature stop codons) have
resulted in multiple species with non-functional peptides (Stewart et al., 2009). It was
initially suggested that mice and rats expressed a functional gene as immunoreactive
GnRH-II was identified in brain tissue (Millar et al., 2001). However, it was determined
that rats had a complete deletion of the gene (Stewart et al., 2009; Pawson et al., 2003)
and mice only retained a partial sequence (Stewart et al., 2009). As such, a functional
gene for GnRH-II has only been found in rhesus monkeys (Urbanski et al., 1999), tarsier
and marmoset (Stewart et al., 2009), humans (White et al., 1998), as well as shrews
(common, tree, and musk; Stewart et al., 2009), horses, guinea pigs and pigs (Desaulniers
et al., 2017). Within the brain, GnRH-II has been found in the medio-basal and pre-optic
regions (Sealfon et al., 1997; Millar, 2002), but it is lowly abundant within areas of the
brain relating to gonadotropin secretion (Rissman et al., 1995) including the porcine
hypothalamus (Desaulniers et al., 2015). Furthermore, GnRH-II has also been located in
the caudate nucleus, hippocampus, and amygdala of primates (Urbanski, 1999; Urbanski,
2012). Considering the location of GnRH-II in the brain, early theories about the
biological function suggested it might play a role in reproductive behaviors rather than
direct stimulation of gonadotropins (Millar et al., 2005; King and Millar, 2005; Rissman
et al., 1995). Reproductive behaviors have been stimulated using analogues of GnRH-II
in sparrows (Maney et al., 1997), marmoset monkeys (Barnett et al., 2006) and restored
behavior in feed restricted shews (Kauffman & Rissman, 2004).
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Interestingly, transcript levels of GnRH-II are highest in peripheral tissues rather
than the brain (Millar et al., 2001), previous work from our group determined that the
highest levels of GnRH-II were localized within the porcine testis, primarily the
seminiferous tubules (Desaulniers et al., 2015). GnRH-II mRNA detected in all examined
tissue types (Desaulniers et al., 2017) as well as within immortalized cell lines such as
ovarian (Choi et al., 2006) and neural lines (Chen et al., 2002).. Nevertheless, given the
wide distribution of GnRH-II across tissue types, it is thought that the peptide serves an
alternate function to GnRH-I.

GnRHR-II. GnRHR-II was first identified in African catfish (Tensen et al.,
1997) and since then has been identified in over 83 mammalian species (Millar et al.,
2001). However, the gene encoding a functional GnRHR-II has only been found in Old
World monkeys, shrews, and pigs (Millar et al., 2001; Neill et al., 2001) as many species
contain coding errors within the GnRHR-II gene that render the protein non-functional.
The gene for GnRHR-II was found on chromosome 1 in humans, as opposed to
chromosome 4 where the human GnRHR-I gene is located, and had a sequence identity
closest to that of fish GnRHR-II (58%) and was thus identified as human GnRHR-II
(Neill, 2002). Similarly, GnRHR-II can be on chromosome 4 in the pig (Stewart et al.,
2009) rather than on chromosome 8 with porcine GnRHR-I. The gene is comprised of 3
exons and two introns, which produces a 7-TM receptor containing an intracytoplasmic
tail on the C-terminus (Neil et al., 2001). These tails are found frequently in other GPC
receptors that are responsible for receptor endocytosis and reduced receptor sensitivity
(Huang et al., 1995). In green monkeys and rhesus macaques, the C-terminal tail was
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determined to have two N-glycosylation sites (Neil et al., 2001) and multiple serine and
threonine residues that are predicted phosphorylation sites (Blomenrohr et al., 1999). In
non-mammalian species, in which GnRHR-II has been described, these sites have been
described as locations critical for both the internalization and desensitization of GnRHRII (Blomenrohr et al, 1999).
Localization patterns of GnRHR-II also differ when compared to that of GnRHRI. Although not fully confirmed, there is some evidence that has demonstrated the
possibility of humans maintaining some level of functionality of GnRHR-II (Neill et al.,
2004). Nevertheless, although the gene appears to be complete, the protein itself may not
be given the frame shift (Neill et al., 2002). Although, other species retain the gene for
GnRHR-II, it is non-functional due to coding errors, such as premature stop codons
(cows and sheep) or frame shifts (chimpanzee and guinea pigs; Desaulniers et al., 2017).
There are only 8 species that encode a functional gene (African green monkey, marmoset,
three shrew, kangaroo rat, orangutan, rhesus macaque, elephant, and pig) GnRHR-II
which pigs are the only livestock mammal that have both a functional GnRH-II and
GnRHR-II (Millar, 2005).
As with GnRH-II, GnRHR-II has been found in most tissues including brain,
pituitary, uterus, ovary, prostate, and testis (Neill et al., 2002). It is also found in a variety
of immortalized cell lines derived from lung (Neill et al., 2001), gastrointestinal tract
(Cederberg et al., 2009), mammary gland (Chen et al., 2002). In addition, GnRHR-II
mRNAs have been detected in cancers of reproductive tissues. GnRHR-II transcripts are
found to be at the highest levels in in the testis, prostate, and breast (Millar et al., 2001).
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As with GnRHR-I, GnRHR-II is part of the GPCR superfamily which is
characterized by 7-TM α-helix domains connected by three intracellular (ICL) and three
extracellular (ECL) loops with an extracellular N-terminal domain (Tensen et al., 1997;
Basith et al., 2018; Figure 6). GnRHR-II shares only 42% homology with GnRHR-I and,
most notably, also possesses a 52 AA intracytoplasmic tail at the C-terminus that is
absent in GnRHR-I. Other structural differences between GnRHR-I and GnRHR-II can
also be found within the TM domains. Within the TM2 and TM7 domains of GnRHR-I
there is a distinct Asn/Asp domain, whereas GnRHR-II contains an Asn/Asp
microdomain that is more commonly found among other GPCRs (Tensen et al., 1997).
The function of this domain is thought to be key in the activation and configuration of the
receptor (Flanagan et al., 1999).
Typical signal initiation of GnRHR-II is similar to that of GnRHR-I, in which
Gαq/11 triggers phospholipase C (PLC) production of inositol 1,4,5-trisphosphate (IP3)
and diacyl glycerol (DAG; Millar, 2003). This, along with increased calcium
mobilization facilitates the activation of protein kinase C (PKC; Millar, 2003; Kang et al.,
2000). Although, description of signaling downstream of PKC from GnRHR-II is limited,
the pathway appears to diverge from GnRHR-I. For example, PKC activation with
GnRHR-I signal transduction results in the activation of extracellular signal-regulated
kinase 1/2 (ERK1/2) as well as a tyrosine-protien kinase, Src (c-Src; Millar et al., 2001).
This differs from GnRHR-II, which does not stimulate c-Src, instead GnRH-II binding to
the receptor results in prolonged activation of ERK1/2 and the catalyzing of p38 mitogenactivated protein kinase (Millar et al., 2001). Currently there are mechanisms of
GnRHR-II signal transduction that remain unknown. It is also worth noting that
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Figure 6 Comparison of GnRH receptors. (A) GnRHR-II (B) GnRHR-I. Both
GnRHR-I and GnRHR-II are 7-transmembrane G-protein coupled receptors. Notably,
GnRHR-II possesses an intracellular tail at the C-terminus that is lacking in GnRHR-I.
From Neill, 2002.
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GnRH-I and GnRH-II can cross-bind to both receptors they do so at a remarkably lower
affinity than they do to their respective receptor (Neill et al., 2002). GnRH-II is capable
of binding to GnRHR-I and stimulating approximately 10% total activity (Neill et al.,
2002) and it has been suggested that this has resulted in the signaling of GnRH-II being
erroneously attributed to GnRH-I (Neill et al., 2004). Initial evidence suggested that
GnRH-II had similar gonadotropin stimulating activities to GnRH-I (Miyamoto et al.,
1984) though this is no longer supported. Furthermore, multiple boar trials have
demonstrated that immunization against GnRH-II (Bowen et al., 2006) and treatment
with a strong GnRHR-II antagonist (Trptorelix-1) have no effect on LH concentrations
(Desaulniers et al., 2015).

Porcine GnRHR-II and Testosterone Production. Previous immunoblotting
experiments performed by our lab using a GnRHR-II specific antibody found that the
receptor is present in testis of boars at 6-fold higher concentrations (Figure 7) than that
of the anterior pituitary (Desaulniers et al., 2015). Similarly, analysis of GnRH-II
concentrations in hypothalamic, anterior pituitary, and testicular homogenates via ELISA
revealed higher concentrations in the testis. Immunohistochemistry and
immunofluorescence trials of porcine testicular tissues determined that both GnRHR-II
and its ligand are present within the testicular compartment. Signal intensity of GnRH-II
is found to be heavily localized within the seminiferous tubule on germ cells. While
GnRHR-II did have low levels of signal intensity originating the seminiferous tubules,
the primary location for GnRHR-II within the testis is in the interstitum on the surface of
Leydig cells (Desaulniers et al., 2017). Furthermore, in both ex vivo and in vivo treatment
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studies our lab determined that GnRH-II stimulated secretion of testosterone in a similar
manner to GnRH-I but with lower levels of LH secretion. These experiments provide
evidence for a LH-independent mode of testosterone production in swine via
autocrine/paracrine signaling with GnRHR-II in the testis
GnRHR-II Knockdown Swine
To further explore the role of GnRHR-II in LH independent testosterone secretion our
laboratory developed a GnRHR-II knockdown swine model (GnRHR-II KD). To do this,
we utilized construct that co-expresses two small hairpin RNA (shRNA) specific to the
porcine GnRHR-II (human U6 promoter) and the floursecent protein ZsGreen driven by
the CMV promoter (Desaulniers et al., 2017). Developmental data was collected using
GnRHR-II KD and control littermate boars at 40, 100, 150, 220, and 300 days of age to
evaluate systemic impacts of GnRHR-II impairment. During pubertal development
GnRHR-II KD boars had reduced predicted testicular volume and testosterone in
circulation (P < 0.05; Desaulniers et al., 2017). However, LH concentrations did not
differ between lines (P > 0.05). Analysis of testicular tissues using digital droplet PCR
(ddPCR) using primers specific to porcine GnRHR-II determined that the relative
expression of GnRHR-II in transgenic boars was reduced by approximately 69%
compared to their control littermates (Desaulniers et al., 2017). We next examined
GnRHR-II KD and control boars at maturity. Mature GnRH-II males had significantly
lower testosterone in circulation (82% less) compared to control littermates (Desaulniers,
2018). Measurements of testis size were taken for both groups, as size of the testis can be
positively correlated with overall steroidogenesis (Walker et al., 2004). There were no
differences in testicular size between GnRHR-II knockdown and control littermates. Thus

27

the differences in circulating testosterone levels were not due to smaller testes, but likely
the result of impaired Leydig cell function (Desaulniers, 2018). Mass spectrometry
analysis intended to target 16 steroid hormones that encompassed mineralocorticoids,
glucocorticoids, androgens, estrogens, and progestogens was performed on the serum
from this same study. Adrenal steroids were not different between the transgenic and
control boars except for 11-deoxycortisol which was reduced in the GnRHR-II KD
animals (Desaulneirs, 2018). However, all steroids of gonadal origin were either
significantly reduced or tended to be reduced in the GnRHR-II KD vs. control boars.
Most interestingly though, mass spectrometry analysis of tissue samples isolated from the
same cohort of animals, revealed no difference for any steroids. This lead us to
hypothesize that there may be impairments in downstream steroid conjugation, secretion
into circulation, or excretion into waste that result in the aberrant circulation of steroids in
the serum of GnRHR-II KD boars.
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Figure 7 Both GnRH-II and GnRHR-II levels are elevated in the porcine testis. (A)
While GnRH-II is present in porcine hypothalamus and anterior pituitary it is highly
expressed within the testis by comparison (P < 0.0001) (B) Western blotting of
anterior pituitary and testis tissues isolated from boars. (C) Quantification of
immunoblot indicating distinct differences in GnRHR-II protein between tissues (P
<0.0001).From Desaulniers et al., 2015.
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Sulfoconjugation in mammals
Sulfation pathway. Sulfoconjugation is the addition of a sulfonate group (SO3-)
onto a biomolecule as a metabolic reaction, this addition occurs most commonly onto a
hydroxyl group (R-OH), but can also occur with amide and thioester groups so long as
the necessary substrates are present. (Runge-Morris et al., 2013). Sulfoconjugates were
first described in 1876 as metabolic waste products excreted in urine and became a
primary focus of biotransformation research (Baumann, 1876). The production of
sulfoconjugates is referred to commonly as ‘sulfation’ as the product of the reaction is
transformed into (R-O-SO3H) that has the chemical classification as sulfate. However, it
is also frequently referenced as “sulfonation” which may denote the production of
chemical compounds such as sulfonic acids (R- SO3H). Sulfation may then be thought of
as the chemical process, which results in a sulfate compound whereas sulfonation is the
movement of a sulfonate group onto a recipient compound that may or may not result in a
sulfate final product. Sulfated biomolecules are ubiquitous throughout biology and are
necessary for a wide range of critical biological functions, (Mueller and Shafqat, 2013)
for example, among vertebrates; sulfates of heparin and chondroitin are vital for the
development of bone and cartilage. Sulfoconjugation reactions are classified as a Phase II
metabolic process due to the reduction of biological activity and increased water
solubility of biomolecules caused by the sulfate addition (Gamage et al., 2005; Sukio et
al., 2016). While initial interest in the pathway was restricted to its function in the
metabolism of xeno- and endo-biotics, there has been a recent growing interest in the role
of the pathway in steroidogenesis and homeostasis (Geyer et al., 2016). Current research
indicates that malfunctions within the pathway lead to fertility complications in men and
can also have impacts on the prognosis of a steroid dependent cancer such as breast and
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prostate cancers (Sánchez-Guijo et al., 2016). The enzymes responsible for
sulfoconjugation have been highly conserved from prokaryote to man and disruption of
the process can be lead to illness or even death (Chapman et al., 2004). There are two
primary enzymes, sulfotransferases (SULTs) and sulfatases (STS), which are involved
with the addition and removal of sulfate groups, respectively. However, the reaction
requires a co-substrate, 3’-phosphoadenosine 5’-phosphosulfate (PAPS), which functions
as the donor of the sulfate group. PAPS requires the activity of an enzyme, PAPS
synthetase, in order to be formed.
PAPS synthase. All sulfonation reactions rely on the presence of PAPS to act as
the universal donor of sulfate. Sulfate is an obligate nutrient from food and drinking
water and is taken up in the gut primarily through solute-linked carrier (SLC) 13 and 26
but also to a small degree by the oxidation of the amino acids, cysteine and methionine
(Dawson, 2012). Due to the inert nature of dietary sulfates, PAPS must undergo
enzymatic activation by PAPS synthase (PAPSS). PAPSS is a two-part enzyme
comprised of ATP sulfurylase located at the C-terminal and an N-terminal adenosine 5′phosphosulfate kinase but due to changes in the genome encoding both enzymes it is
transcribed as a single protein with two catalytic subunits and is not classified as a
heterodimer (Harjes et al., 2005). PAPS is highly conserved between species, with the
amino acid sequence of humans and mice sharing 96% homology (Strott, 1996). In all
eukaryotic species, with the exception of humans, PAPS is formed by a bi-functional
PAPSS (van den Boom et al., 2012). Activated PAPS is used by sulfotransferases in the
sulfation of a wide variety of biomolecules so long as the prerequisite hydroxyl or amino
groups are available.
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PAPS acts as the universal donor for all sulfation reactions and is responsible for
the modification of many extracellular proteins and substances of low-molecular weight
(van den Boom et al., 2012). For instance, sulfation of proteoglycans is necessary for
lubrication of joints by maintaining water pressure in the joint capsule (Harjes et al.,
2005). PAPS formation is also the rate-limiting step of the sulfation pathway, so the
process is regulated by general availability of the PAPS co-substrate (Kauffman, 2004).
PAPS formation occurs in a two-step process handled by either side of the bi-functional
PAPS synthase (Figure 8). Firstly, the AMP moiety of ATP is transferred into sulfate via
catalysis by the ATP sulfurylase site of PAPS synthase which results in adenosine-5’phosphosulfate. This reaction is highly endergonic, requiring the pyrophosphate be
cleaved and an additional phosphorylation step to complete the reaction. Phosphorylation
is then performed by the adenosine-5’-phosphosulfate kinase portion of PAPS synthase
and occurs at the 3’-hydroxyl group resulting in the final product of PAPS.

Sulfotransferases. SULTs are enzymes that are classified into membrane bound
Golgi enzymes or cytosolic enzymes. SULTs associated with the Golgi are responsible
for the sulfation of a wide variety of proteins, carbohydrates, and proteoglycans.
Cytosolic SULTs tend to be responsible for the modification of primarily hydrophobic,

Figure 8 The two step mechanism of PAPS synthesis. 1) AMP moiety of ATP is transferred into sulfate via catalysis by the
ATP sulfurylase site of PAPS synthase which results in adenosine-5’-phosphosulfate intermediate. 2) Phosphorylation by the
adenosine-5’-phosphosulfate kinase portion of PAPS synthase occurs at the 3’-hydroxyl group resulting in PAPS. This
reaction is the rate-limiting step of all sulfation.
32
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low-molecular weight compounds such as xeno-biotics, phenols and steroids. SULTs are
a superfamily of multigene enzymes with no fewer than 54 members. The superfamily is
arranged into 9 primary families and 14 sub-families. SULT naming methodology
identifies the enzyme by both family and sub-family (e.g., SULT2A1 where 2 is the
family and A is the sub-family). Classifications are given based on amino acid homology,
family members must have at least 45% homology and sub-families must have at least
60% homology (Gamage et al., 2006). Structurally, SULTs are primarily spherical
enzymes capable of forming both hetero- and homo-dimers (Chapman et al., 2004). The
family of sulfotransferases that are of greatest interest for this literature review is the
SULT2 family which is present in no fewer than 94 mammalian species (Table 2), and is
comprised of the hydroxysteroid sulfotransferases whose target compounds include
DHEA, pregnenolone and androgens (Gamage et al., 2006). The active site is comprised
of five parallel β-sheets flanked by α-helices (Gamage et al., 2006; Figure 9A), similar to
nucleoside kinase enzymes (Strott, 2002). The β-sheets comprise the majority of PAPS
binding and catalytic sites but are covered by α-helices as the catalytic site is
hydrophobic L-shaped pocket (Gamage et al., 2006). Substrate binding sites are “plastic”,
meaning that the enzyme is capable of changing its overall shape in order to
accommodate a wide variety of substrates (Gamage et al., 2006)
The greatest area of variation, however, is in the binding sites (Chapman et al.,
2004). Despite the high level of promiscuity, some varieties have a preferential substrate
while still being able to act upon other compounds. Unlike the substrate binding sites, the
PAPS binding site is highly conserved among all variants indicating that it plays a critical
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Table 2 Identification of SULT2A1 gene within 94 mammalian species via NCBI gene
database searches.
Order

Common name

Genus species

Afrosoricida

Lesser hedgehog tenrec

Echinops telfairi

105979776

Artiodactyla

Alpaca

Vicugna pacos

102528443

Arabian camel

Camelus dromedarius

105098927

Bactrian camel

Camelus bactrianus

105062573

Blue whale

Balaenoptera musculus

118885428

Cattle

Bos taurus

Common warthog

Phacochoerus africanus

125134229

Elk

Cervus canadensis

122421698

Pig

Sus scrofa

Red deer

Cervus elaphus

122692255

Scimitar oryx

Oryx dammah

120872214

Sheep

Ovis aries

101120103

Water buffalo

Bubalus bubalis

102395467

White-tailed deer

110150756

Wild Bactrian camel

Odocoileus virginianus
texanus
Camelus ferus

Big brown bat

Eptesicus fuscus

103297671

Black flying fox

Pteropus alecto

102890032

Brandts bat

Myotis brandtii

102254636

Common vampire bat

Desmodus rotundus

112312826

David's myotis

Myotis davidii

102762941

Egyptian fruit bat

Rousettus aegyptiacus

107516041

Great roundleaf bat

Hipposideros armiger

109390976

Greater horseshoe bat

Rhinolophus
ferrumequinum
Myotis myotis

117034323

Phyllostomus hastatus

123822928

Indian flying fox

Pteropus giganteus

120606999

Jamaican fruit-eating
bat
Kuhl's pipistrelle

Artibeus jamaicensis

119065861

Pipistrellus

118716937

Large flying fox

Pteropus vampyrus

105304188

Natal long-fingered bat

Miniopterus natalensis

107540047

Pale spear-nosed bat

Phyllostomus discolor

114511474

Dermoptera

Sunda flying lemur

Galeopterus variegatus

103607526

Didelphimorphia

Agile Gracile Mouse
Opossum

Gracilinanus agilis

123239008

Chiroptera

Greater mouse-eared
bat
Greater spear-nosed bat

NCBI Gene ID

533560

641359

102518264

118657508
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Diprotodontia

Common brushtail
possum
Common wombat

Trichosurus vulpecula

118838698

Vombatus ursinus

114053539

American pika

Ochotona princeps

101532090

European rabbit

Oryctolagus cuniculus

100008598

Microbiotheria

Monito del monte

Dromiciops gliroides

122748522

Perissodactyla

Ass

Equus asinus

106845150

Plains zebra

Equus quagga

124251313

Przewalskis horse

Equus przewalskii

103555784

Angola colobus

Colobus angolensis
palliatus
Rhinopithecus bieti

105500701

Saimiri boliviensis

101034912

Lagomorpha

Primate

Black snub-nosed
monkey
Bolivian squirrel
monkey
Chimpanzee

Pan troglodytes

108539899

456409

Coquerels sifaka

Propithecus coquereli

105817707

Crab-eating macaque

Macaca fascicularis

102130325

Drill

Mandrillus leucophaeus

105531904

Francois' leaf monkey

Trachypithecus francoisi

117091485

Gelada

Theropithecus gelada

112611897

Golden snub-nosed
monkey
Gray mouse lemur

Rhinopithecus roxellana

104673376

Microcebus murinus

105869600

Green monkey

Chlorocebus sabaeus

103234953

Human

Homo sapiens

Ma's night monkey

Aotus nancymaae

105713148

Northern white-cheeked
gibbon
Olive baboon

Nomascus leucogenys

100603984

Papio anubis

101000955

Panamanian whitefaced capuchin
Philippine tarsier

Cebus imitator

108283861

Carlito syrichta

103256265

Pig-tailed macaque

Macaca nemestrina

105478620

Pygmy chimpanzee

Pan paniscus

100971784

Rhesus monkey

Macaca mulatta

Ring-tailed lemur

Lemur catta

123623885

Silvery gibbon

Hylobates moloch

116479417

Sooty mangabey

Cercocebus atys

105595217

Sumatran orangutan

Pongo abelii

100431471

Tibetan macaque

126943497

Ugandan red Colobus

Macaca thibetana
thibetana
Piliocolobus tephrosceles

Western gorilla

Gorilla gorilla

101137965

White-tufted-ear
marmoset

Callithrix jacchus

100413663

6822

717600

111520101
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Proboscidea

Indian Elephant

Elephas maximus indicus

126086181

Rodentia

African woodland
thicket rat
Alpine marmot

Grammomys surdaster

114634381

Marmota marmota
marmota
Myodes glareolus

107151302

Banner-tailed kangaroo
rat
Creeping vole

Dipodomys spectabilis

122125776

Microtus oregoni

121449068

Desert hamster

Phodopus roborovskii

127238564

Eurasian water vole

Arvicola amphibius

119802299

Golden hamster

Mesocricetus auratus

101831195

Golden spiny mouse

Acomys russatus

127203615

Gray squirrel

Sciurus carolinensis

124974882

House mouse

Mus musculus

20859

Lesser Egyptian jerboa

Jaculus jaculus

101599550

Norway rat

Rattus norvegicus

Pacific pocket mouse

125368433

Reed vole

Perognathus longimembris
pacificus
Peromyscus maniculatus
bairdii
Microtus fortis

Ryukyu mouse

Mus caroli

11029913

Shrew mouse

Mus pahari

102254636

Thirteen-lined ground
squirrel
White-toothed pygmy
shrew
Woodchuck

Ictidomys tridecemlineatus

101965764

Suncus etruscus

126027529

Marmota monax

124107985

Sirenia

Florida manatee

101344801

Tubulidentata

Aardvark

Trichechus manatus
latirostris
Orycteropus afer afer

Bank vole

Prairie deer mouse

125395479

24912

107399532
126494654

103213144
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Figure 9 (A) 3D crystal structure of SULT2A1 with 3-beta-hydroxy-5-androsten-17one (epiandrosterone) in the active site. Adapted from Molecular Modeling Database.
MMDB ID: 19485. (B) 3D crystal structure of STS with transmembrane domain
anchoring the enzyme to the interior of the endoplasmic reticulum. Adapted from
Molecular Modeling Database. MMDB ID: 134611

38

role in enzyme function. Mutagenesis studies found 3 amino acids (Lys48, His108,
Lys106) within the PAPS binding site that are necessary for enzymatic action. His108 is
required for the catalytic site to function, whereas Lys48 and Lys108 can only be
replaced with arginine residues to avoid complete loss of function (Chapman et al.,
2004).
The mechanism by which sulfotransferase performs conjugations of the target
substrates has become better understood after the structure of the enzyme was described.
The order of SULT binding has yet to be elucidated, with conflicting evidence suggesting
that the nucleotide binds first or perhaps the mechanism is random (Wang et al., 2014).
Recent investigations into the mechanism of action have suggested that it is likely an inline sulfonyl-transfer that is equivalent to the phosphoryl transfer that many kinases
perform (Kakuta et al., 1998). Sulfoconjugation requires PAPS docking with its
designated binding site on the SULT enzyme and being moved closer to the nucleophile
on the target compound (Hobkirk, 1985). His108 likely assists by deprotonating the
substrate and allowing the nucleophile attack. Two possible transition states for this step
have been proposed. Associative transition is where SO3- group breaks away from PAPS
close to the incoming nucleophile (Chapman et al., 2004). In dissociative transition, the
charge on PAPS is neutralized followed by the lengthening of the O-S bond. The
nucleophile is then deprotonated and continues with the attack on PAPS (Hobkirk, 1985).
The final product is a sulfated biomolecule and PAP, that can then participate in
desulfation via steroid sulfatases or be re-sulfated by PAPS synthase.
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Steroid Sulfatase. As with PAPSS and SULTs, STS is highly conserved
throughout evolution. STS enzymes have a high homology at their N-terminus and an
aldehyde residue (α-formylglycine; FGly) that is added following the translation step
(Hanson et al., 2004). FGly is present in both prokaryote and eukaryote STS and
mutagenesis testing indicates that it is critical for enzyme function, similar to His108 in
SULTs (Hanson et al., 2004). Currently, 15 separate STS enzymes have been identified
in humans, ranging from 500-600 AA in length (Reed et al., 2005). Separate genetic
illnesses have been linked to deficiency in 8 of the 15 STS enzymes with deficiency in
more than one classified as Multiple Sulfatase Deficiency (Hanson et al., 2004). To
illustrate the biological necessity of sulfatase enzymes, STS mRNA levels and enzymatic
activity are increased within tumors of hormone-dependent cancers (breast and prostatic;
Reed et al., 2005). As such, sulfatase enzymes are of prime interest in oncology research.
STS is localized within the endoplasmic reticulum (ER; Miller et al., 2014) which
separates it from SULTs and prevents the futile cycling of conjugates. The enzyme is
nearly spherical except for membrane bound isoforms that contain a transmembrane
domain (Hanson et al., 2004). The C-terminus has 4 antiparallel β-sheets and 1 large αhelix that lies perpendicularly over them, housing FGly (Hanson et al., 2004; Figure 9B).
There is a greater level of variation in the C-terminus, leading to speculation as to
substrate specificity. The N-terminus, on the other hand, has a similar structure to
alkaline phosphatases but are entirely different in their sequence (Hanson et al., 2004).
The STS active site is comprised of 10 polar residues that are connected on a
single divalent metal cation (Lukatela et al., 1998). The cation is typically Ca2+, but
occasionally Mg2+ is used. The catalytic site of STS is lined with positively charged
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residues that are responsible for binding anionic sulfate (Hanson et al., 2004). The high
rate of conservation for this portion of the enzyme supports the conservation of the
mechanism (Reed et al., 2005). The catalytic site of STS is lined with positively charged
residues that are responsible for binding anionic sulfate (Hanson et al., 2004). The high
rate of conservation for this portion of the enzyme supports the conservation of the
mechanism (Reed et al., 2005). In order for sulfoconjugation to be performed, PAPS
must first be made. The first step is catalyzed by the ATP sulfurylase portion of PAPS
synthetase. It utilizes inorganic phosphates, obtained by diet and through the degradation
of proteins and nucleosides, and ATP to overcome the unfavorable equilibrium (Keq ~
10-7) of forming APS (Strott, 1996). Once 5′-phosphosulfate is formed, the 5′phosphosulfate kinase action utilizes ATP one more time that results in the end-products
PAPS and ADP.
The reverse mechanism of sulfate ester hydrolysis is slightly more complex than
the initial sulfoconjugation. It begins by one of the oxygen molecules of sulfonate
performing a nucleophile attack on the aldehyde of FGly and forming a sulfur diester. A
water molecule then attacks the sulfonate at the oxygen that is bound to the original
molecule that was conjugated. (Hanson et al., 2004). This attack then releases the now
unconjugated and biologically active molecule. The sulfate must then be removed from
the enzyme in order for further reactions to take place. The hydroxyl group on FGly that
formed with the initial nucleophile attack then has its hydrogen attack the bond
connecting the sulfate. This restores the original FGly aldehyde and releases the sulfur
group to form HSO4- (Hanson et al., 2004). There is some speculation that variations of
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the FGly group contain two hydroxyl groups and carry out a slightly different method of
hydrolysis but there is little evidence to support this claim.
Efflux and Influx of Sulfates. Biomolecules that have undergone sulfation
become hydrophilic and are unable to diffuse across the cell membrane. Therefore, the
require active transport for movement in and out of a cell. Given that these compounds
are anionic, they can be transported by members of two major superfamilies of protein
transporters, ATP-binding cassette (ABC) and solute carrier (SLC) transporters. While
evidence suggests that these transporter families are capable of bidirectional transport it is
classically thought that ABCs are responsible for efflux and SLCs are responsible for
influx (Roth et al., 2012). The SLC superfamily is comprised of 52 gene families, of
which 2 are involved in the movement of sulfated steroids. Organic solute carrier partner
(OSCP) found within the SCLO superfamily and organic anion transporters (OAT)
wound within the SLC22A family (Fietz et al., 2013).
Several transporters have become targets of interest due to their localization
within the testis and broad range of specificity, which includes sulfates. Organic anion
transporting polypeptide 6A1 (OATP6A1), organic solute carrier protein 1 (OSCP1), and
sodium-dependent organic anion transporter (SOAT) were all determined to be prime
candidates because of their notably high levels of expression within the testis (Fietz et al.,
2013). Although OSCP1 and OSCP6A1 were not analyzed, immunohistochemistry
localized expression of SOAT to within pachytene primary spermatocytes (Fietz et al.,
2013). In another study using genetically modified rats with reduced expression levels of
SOAT mRNA, no impact on spermatogenesis was detected. However, they did detect an
increase in circulating cholesterol sulfate (Bakhaus et al., 2018). Each member of these
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transporter families has a broad specificity for sulfates depending on the particular
protein transporter but, as with SULTs, each transporter may have a slightly higher
specificity depending on the steroid sulfate in question.
In contrast, efflux of steroid sulfates is mediated primarily through the ABC
transporter family multidrug-resistant protein (MRP; Imai et al., 2003). ABC transporters
are typically associated with cancer drug resistance and rely on the binding and
hydrolysis of ATP to facilitate the movement of substrates across the cellular membrane
(Yin et al., 2011). While there have been 13 MRP family members identified, MRP1 and
MRP4 (aslo known by their gene identifiers ABCC1 and ABCC4), have the highest
efficiency in efflux of steroid sulfates (Mueller et al., 2015). While MRP1 and MRP4 are
the most efficient, they are not the only MRP transporters that have some level of steroid
sulfate specificity. The primary transporters found within the testis are MRP1, MRP2 and
MRP4 (Fietz, 2018).
The standard structure of MRP transporters consists of twelve transmembrane
helices that unlike other transporters with independently placed helices have a significant
twist to them (Locher, 2009). The twist formed by these transmembrane domains forms
an open pore when in an ATP-bound state, with the inner cavity being relatively
hydrophilic (Locher, 2009). Along with the transmembrane domains, MRP transporters
additionally have nucleotide-binding domains that contain conserved peptide sequences
and intercellular loops of ATP-binding motifs where hydrolysis takes place (Bakos,
2006). MRP transporters function using active transport that require ATP hydrolysis but,
unlike P-type ATPases, they do not form phosphorylated intermediates during their cycle.
Upon binding of ATP to the transporter, a conformational change exposes the extrusion
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site for the release of the substrate. Following extrusion, the hydrolyzed ADP is released
and the transporter is returned to a closed conformational state (Locher, 2009).
Currently, as with many transport proteins, there is no resolved crystal structure
for OSCP transporters, so most 3-dimensional models are built using homology
modeling. OSCP transporters are predicted to have 12 transmembrane domains with the
terminus of either end residing intracellularly (Roth et al., 2012). The second and fifth
loops have sites for N-glycosylation, though placement is dependent on individual
transporters (Hanggi et al., 2006). However, the mechanical action of transports of
substrates via OSCPs remains somewhat controversial (Roth et al., 2012). While it is well
known that transport is ATP mediated and independent of sodium, the actual driving
force for the transport mechanism remains unknown (Roth et al., 2012). While there is
some evidence that OSCPs may facilitate transport by exchanging their substrate for
bicarbonate, glutathione, or glutathione conjugates, there may be individual differences
based on each transporter (Luethold et al., 2009). pH may also play a role in SCL
mediated transport, with several studies showing that OTAP2B1 has increased activity at
acidic pH but this may also be dependent on both substrate and localization (Kobayashi et
al., 2003). However, more work is needed to elucidate the structure and mechanisms of
this family of transporters. Members of both the SLC and MRP superfamilies are found
abundantly across tissue types and presence is correlated with the concentrations of
intracellular steroids (Mueller et al., 2015; Figure 10).
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Figure 10. Following synthesis, steroids can undergo conjugation by sulfotransferases
that have hydroxysteroid specificity (i.e. SULT2A1, SULT1E1). These
sulfoconjugates are then shuttled out of the cell into circulation via transporters with
sulfate specificity (e.g. Multidrug Resistance Transporters). Upon reaching target
tissues conjugates are taken up importers (e.g. organic solute carrier proteins) and then
freed by steroid sulfatase within the ER. The free steroid can then enter the nucleus to
participate in gene regulation.
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Role in Reproduction. Due to the role that sulfation plays in steroidogenesis,
there has been a recent increase in research into the function of the pathway in the
reproductive process. Sulfated steroids are present in circulation at significantly higher
concentrations than their unconjugated forms. DHEA-S values are up to 100-times higher
than DHEA and estrone sulfate is often found at levels 10-20 times higher than estrone or
estradiol-17β (Pasqualini, 2004). Large amounts of estrone sulfate (E1S) in pregnant
cows have been also described as secretory products of the placenta which suggests in
important role in pregnancy (Geyer et al., 2016), this true for other ungulates (pigs,
horses, and camelids) as well. Furthermore, due to their longer half-lives and increased
water solubility, sulfoconjugated steroids are developing increased interest as a potential
form of long-term storage for steroid hormones. In that vein of thought, swine are optimal
model to study sulfoconjugation due to their high concentrations of sulfated steroids and
greater levels of SULT and STS activity (Mutembei et al., 2009). It was following the
discovery of co-localized estrogen receptors, steroid sulfatases, and sulfotransferases that
greater interest in the potential role of steroid conjugates on reproduction and
reproductive diseases gained traction (Schuler et al., 2008).
Steroid synthesis in boars is characterized by the high level of sulfated steroids,
including both estrone sulfate and DHEA sulfate (Schuler et al., 2014). The conjugation
of steroids to sulfates renders them biologically inactive and unable to bind with nuclear
receptors and strongly increases the polarity of steroids (Kuiper et al., 1997). Once
sulfated steroids are secreted into circulation, they are avidly bound by serum albumin
and to a lesser extent by corticosteroid binding globulin (CBG, transcortin) and sex
hormone binding globulin (SHBG; Dawson et al., 2012). In the case of swine, this pattern
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of binding offers potential insight into peripheral steroid transport as swine are not known
to have SHBG (Aydin et al., 2016). Steroid sulfates have also been suggested to act as a
reservoir for biologically active steroids. Evidence for this primarily relies on the
reversible nature of steroid sulfates compared to glucuronides which are irreversible
(Schiffer et al., 2018) and due to the fact glucuronides are preferentially excreted as waste
over sulfates (Vargatu, 2016).
Follicular sulfates. The impact of sulfated steroids within the ovary is yet to be
fully understood but interest in their role in follicular development is growing. Steroids
are an essential regulator of follicular development that require multicellular
steroidogenesis for appropriate ovarian function. The expression of the estrogen
sulfotransferase (SULT1E1) and STS in has been investigated in equine follicles during
treatment with human chorionic gonadotropin (hCG) to induce ovulation and
luteinization (Brown, 2006). Results of this study indicate that following injection of
hCG, transcription of SULT1E1 increases significantly within the subsequent 30-39h
(Brown et al., 2006). Inversely, STS transcripts are seen to decrease in pre-ovulatory
follicles following treatment within the same period. This evidence suggests that downregulation of STS in pre-ovulatory follicles may provide additional support to decrease
the synthesis of 17β-estradiol following the LH surge. Within follicles, the composition
of follicular fluid can affect the quality of an oocyte as well as the potential embryos
(Wallace et al., 2012).
More recently, it has been found that follicular cells are capable of producing bile
acids, which are one of the many primary targets of SULTs (Smith et al., 2009). It has
been demonstrated that all aspects of bile acid production are present within the ovary
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(Smith et al., 2009). However, given the highly privileged nature of the follicle, it is
suggested that bile acids may play a role other than a detergent or cholesterol substrate.
The full characterization of the follicle specific bile acids remains unelucidated. To
understand the nature of ovarian steroid metabolism, bovine ovaries were collected at a
slaughterhouse and then categorized based on estrus stage. The ovaries were then
analyzed via immunohistochemistry for the presence of SULT1E1 and STS (Blaschka et
al., 2017). It was found that, regardless of estrus stage, that small amounts of STS could
be detected in the granulosa cells of antral and secondary follicles and within the
endothelium of neighboring blood vessels (Blaschka et al., 2017). SULT1E1 was found
to be restricted, regardless of estrus stage, to the granulosa cells of antral follicles
(Blaschka et al., 2017). Further investigation into the nature of the sulfate pathway is
needed to elucidate the role these compounds play in ovarian and follicular environments.
Steroid Sulfates in Pregnancy. Cholesterol sulfate originating from both maternal
and placental tissues are essential for the production of steroid sulfates including DHEA
sulfate. While a fetus has limited capacity for steroidogenesis, it is capable of
synthesizing DHEAS within the zona reticularis of the adrenal gland (Dawson et al.,
2012). Fetal DHEAS circulated to the placenta accounts for the majority of (~90%) all
synthesis of estrone, estradiol, and other fetal steroids (Dawson et al., 2012). Sulfated
steroids are the primary form of steroids provided to fetal tissues such as placental
estradiol-3-sulfate that enters the brain to stimulate secretion of adrenocorticotropin
(ACTH) and the hypothalamus-pituitary-adrenal (HPA; Wood, 2005) axis. The
importance of the sulfation pathway can be further demonstrated in mice that lack
expression of SULT1E1, wherein placental thrombosis and mid-gestational fetal loss
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occurred (Tong et al., 2005). SULT1E1 is abundantly expressed within placental tissues
and is necessary for the production of estrone sulfate, estradiol-3-sulfate, and estriol
sulfate (Dawson et al., 2012). Male SULT1E1 KO mice, which have abundant SULT1E1
expressed in the testis, experience hyperplasia and hypertrophy of Leydig cells as well as
reduced sperm motility and smaller litters compared to age-matched control males
(Dawson et al, 2012). These data suggest that the sulfation pathway plays a critical role in
maintaining pregnancy and in the reproductive function of males.
Sulfates in Males. Currently, while the true nature of multiple steroid sulfates
within the boar testis are still unknown, the sheer volume of sulfate conjugates produced
by boars indicates an imperative biological function (Schuler et al., 2014). Measurements
taken from testicular tissue and from comparative measurements of the testicular vein and
artery provide support that these sulfates are predominantly originating from the testis
(Balieu et al., 1967; Raeside et al., 2006). Among the sulfotransferase enzymes, two have
been identified as potential key players in steroid regulation in the boar testis, SULT2A1
and SULT1E1 (Laderoute et al., 2018). Both of these enzymes have been localized within
the testis; however, the exact substrate specificity of SULTs has not been fully elucidated
in swine so inferences have been made based on human sulfotransferases (Geyer et al.,
2017). Boars are unique in that they are the only species that have been identified
exhibiting abundant production of estrogen sulfates within the testicular-epididymal
compartment (Schuler et al., 2018).
Interestingly, porcine Leydig cells express both SULTs (Figure 11) and STS
(Figure 12) which evidence suggests are kept in separate subcellular regions to prevent
futile cycling and regulate where sulfated steroids enter the pool of biologically available
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steroids (Gamage et al., 2005). In effort to characterize the relationship between
conjugated and non-conjugated steroids, blood samples were collected from the testicular
veins of six post-pubertal boars for 6 hours in intervals of 20 minutes (Schuler, 2014).
Following this, concentrations of DHEAS, E1S, PREGS, estradiol-17β- sulfate,
testosterone, and androstenedione were measured via LC-MS/MS (Galuska et al., 2013).
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Figure 11. Immunohistochemistry localization of SULT2A1 within the porcine testis.
(A) IHC of porcine liver with heavy staining for positive control. (B) Negative control
of porcine liver using non-immunized rabbit IgG. (C) IHC of SULT2A1 in testis
samples with moderate staining localized to interstitum. (D) Porcine testis negative
control with non-immunized rabbit IgG. From Schuler et al., 2018.
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Figure 12. Immunohistochemistry of steroid sulfatase (STS) within the porcine testis.
(A) IHC of porcine testis for STS with localization to the interstitum. (B) Negative
control of porcine testis using non-immunized rabbit IgG. From Schuler et al., 2018.
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In spite of the identical genetics of the boars in the study (Pietrain x Landrace) the
steroid concentrations had a wide range of variation. However, the results did indicate
that both the free and conjugated forms of steroids in boars experience a low frequency,
pulsatile secretion pattern (Galsuka et al., 2013). In another trial where seven boars were
treated with hCG, serum concentrations of both free and sulfated steroids experienced
rapid increase (Geyer et al., 2017). These results indicate that, following synthesis, a
large proportion of conjugates are released into peripheral circulation. The biological role
of sulfates as inactive steroid destined for target tissues is supported by the high levels of
STS within target tissues such as the prostate (Nakamura et al., 2006). In boars treated
with letrozole, an aromatase inhibitor, there were no differences in estrone and estradiol
in prostate samples but there was a significant reduction in sulfoconjugates in both the
testis and prostate (Kucera et al., 2019) which would indicate that conjugates originating
from the testis are the primary source of estrogens for prostatic tissue. This is also
supported by the tissue concentrations of aromatase, which is 1000X higher in the testis
than the prostate (Kucera et al., 2019).
While the presence of high concentrations of sulfated estrogens in swine has long
been known, their function and synthesis have not been fully investigated. Previous
experiments involving blood from both spermatic cord lymph fluid and testicular venous
blood have indicated that the testicular-epididymal compartment is the primary source for
sulfated estrogens in boars (Schuler et al., 2018). The use of real-time RT-qPCR,
immunohistochemistry, and western blots performed on testicular extracts and segments
of caput, corpus, and cauda epididymis has localized areas of enzyme synthesis and
expression. STS mRNA is found to be highly localized in both the testis and the cauda
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epididymis with considerably lower expression in the corpus epididymis (Schuler et al.,
2018). However, western blot band intensity was routinely higher in the testis with
variable intensity across all segments of epididymis and when paired with
immunohistochemistry enzyme presence was localized further to intense cytoplasmic
staining within Leydig cells (Schuler et al., 2018). Inversely, it was found that mRNA
expression of SULT1E1 to be all but non-existent within the testis with high expression
levels in the caput epididymis (Schuler et al., 2018). This was further confirmed with
western blot and immunohistochemistry analyses (Schuler et al., 2018). This study
concluded that the co-localization of SULT1E1, STS, and aromatase in Leydig cells
offers greater capability for the production of biologically active estrogens and may have
impacts on not only steroid homeostasis but also spermatogenesis (Schuler et al., 2018).
Another study used radiometric enzyme assays for both STS and SULT1E1 to measure
enzymatic activity in the caput, corpus, and cauda epididymis of Polish Landrace boars
castrated at 8, 12, or 16 months (Zdunczyk et al., 2012). Enzymatic activity increased
with age, implying that the sulfation pathway plays an important role in estrogen
metabolism and bioactivity (Zdunczyk et al., 2012). Collections of peripheral and
testicular arterial and venous blood from boars aged between 98 d (peripubertal) days and
2793 d (elderly) it was found that there was a significant age dependent increase of E1
and E1S but only for peripheral collections (Hoffmann et al., 2009). Comparisons of
concentrations of E1, E1S, testosterone, and progesterone were also analyzed between
testicular vein and artery, which found venous concentrations tending to be higher with
significant differences for both E1 and progesterone (Hoffmann et al., 2009). Regulation
of the sulfation of steroid hormones via gonadotropin signaling is not fully understood
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and there is a lack of publications regarding regulation and as such, it requires further
elucidation. However, following hypophysectomy of mice, enzymatic activity of
SULT1E1 ceased but daily injections of LH rescued activity suggesting, that there is
cross talk between LH receptors and SULT activation pathways (Song, 2001). To further
compound on this, patients being treated for cyclic endometriosis using GnRH agonists
expressed an inhibition of STS (Maitoko and Sasaki, 2004). Although it is worth noting
that treatment with GnRH agonists, which have a longer half-life than GnRH, leads to
down-regulation of endogenous GnRH and a decrease in pituitary receptors. This downregulation leads to a further decrease in LH and FSH secretion and a subsequent
hypoestrogenic state. It is unclear if STS inhibition is the direct result of GnRH agonists
or simply due to a lack of substrate availability (Maitoko and Sasaki, 2004).

Role in Disease. Dysregulation of the sulfation pathway can lead to a variety of
pathologies and in recent years sulfation proteins have been suggested as potential targets
for therapies for a broad spectrum of disorders. Genetic mutations of PAPSS and of some
other members of the SCL transporter family have resulted in multiple types of
glycosaminoglycan (GAG) related skeletal dysplasias (Paganini et al., 2020). Mutant
mice lacking intestine specific PAPSS show increased sensitivity to colitis and are more
susceptible to cancers of the bowel (Xu et al., 2021). Furthermore, it has also been shown
that steroid sulfates may play a role in neurodegenerative diseases. Decreased levels of
SULT activity and lower overall levels of steroid sulfates care considered risk factors
relating to Alzheimer’s, Parkinson’s, and multiple sclerosis (Viktu et al., 2022). Both
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elevated and depressed activities of SULTs and STS are heavily implicated as factors
relating to multiple diseases which makes them prime targets for further investigation.
Steroid Sulfatase Deficiency (X-Linked ichthyosis). Individuals with deletions
and mutations of the STS gene develop a dermatological disorder known as “X-linked
ichthyosis” (XLI), in which nearly 80% of all afflicted patients have a total deletion of
the STS gene (Fernandes et al., 2010). STS deficiency is also one of the more commonly
inherited metabolic disorders, which accounts for 1:6,000 live births and has no variation
in regards to ethnicity or geographical region (Craig et al., 2010). Clinically, the first
signs of STS deficiency (STSD) may present at or prior to parturition as the appropriate
desulfation of DHEAS and the synthesis of estrogens from DHEA are necessary for the
cervix to adequately soften (Zuidema et al., 1986). Mothers of STS deficient children
frequently report delayed or prolonged labor because of insufficient dilation of the cervix,
which is a severe birth complication where perinatal death is a high risk (Rizk and
Johansen, 1993). Fortunately, prenatal diagnosis of this particular deficiency is possible
due to decreased maternal estrogen excretion, and thus decreased estradiol (Glass et al.,
1998). XLI was first identified in 1960 as unique vitiation of ichthyosis –disorders of the
skin that are characterized by abnormal keratinization—due to its pattern of inheritance
as well as the unique appearance of the skin. Ichthyosis disorders of the skin, in general,
are classified by the development of patches of keratin that frequently resemble the scales
of a fish hence the origin of the terminology, from the Greek ichthys meaning fish
(Mueller et al., 2015).
The development of the hyperkeratosis seen in patients stems from the impaired
cholesterol metabolism that is brought on the mutation of lack of STS. STS is responsible
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for metabolism of cholesterol sulfate into cholesterol in the stratum granulosum and the
stratum corneum of the skin (Fernandes et al., 2010). Cholesterol sulfate serves a function
in the skin, in which it promotes stability within a cell membrane and results in the
cohesion of cells. When not broken down by STS the abundance of cholesterol sulfate
results in increased retention of cells, resulting in the visible development of scales.
However, skin disorders are not the only complication STS deficient patients may
experience, with up to 20% of cases also reporting cryptorchidism which is a risk factor
for the development of testicular cancers (Traupe and Ropers, 1982). It is unknown if the
maldescent of the testis is directly the result of the deletion of the STS or if it occurs in
tandem with the deletion of neighboring genes as reported cases tend to no undergo
genetic characterization. Individuals with STSD can also exhibit reduced androgen
synthesis, though there are very few investigations into steroid metabolism, which results
in compensatory action from outside of the testis (Idkowiak et al., 2016).

Cancer. While phosphorylation and other post-translational modifications have
been investigated in relation to their impact on oncology, the role of sulfates have gone
largely unrecognized. Endocrine-related cancers are defined by their altered regulation of
steroid metabolism but only within the past couple decades that interest in the impact of
the sulfation pathway on malignancy has begun to surface. Alterations in the synthesis of
the sulfotransferase that preferentially conjugates estrogens, SULT1E1, is correlated to
the severity and outcome of estrogen dependent cancers (Hirata et al., 2008).
Furthermore, SULT1E1 is known to be expressed at higher levels in healthy cells
compared to cancer cells that are estrogen receptor (ER) positive (Choi et al, 2005).
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Investigations into therapies for ER positive cancers is critical, as two-thirds of all
diagnosed breast tumors are positive for estrogen receptors (Potter, 2018). One study that
over expressed SULT1E1 and PAPSS in ER cancer cells found that the cells had reduced
estrogen-stimulated proliferation as well as increased apoptosis (Xu et al., 2012). It is
important, however, to take into account the response to changes brought about by other
SULT enzymes and members of the sulfation pathway. SULT1A1, for instance, has a
specificity that includes phenolic and estrogenic compounds but is also know to
bioactivate carcinogens (Han et al., 2004). Tamoxifen, a compound frequently used in the
treatment of estrogen dependent cancers, is also metabolized to its active metabolite (4OH TAM) via SULT1A1. Polymorphisms of SULT1A1 can also be implicated in
survival rates of patients; in one case, a single protein alteration (Arg213→His213) had
significantly reduced thermos-stability and enzymatic activity (Norwell et al., 2000).
Patients with this polymorphism were found to have reduced rates of survival compared
to those who did not have the allele mutation when treated with tamoxifen (Norwell et
al., 2000). Other trials involving tamoxifen have indicated that the sulfated 4OH-TAM
acts as a potent activator of apoptosis of cancer cells, which leads to an increased rate of
survival of patients without the impaired polymorph (Wegman et al., 2005).
Sulfotransferases are not the only members that play roles in tumor development
and long-term prognosis of patients. Recent studies have found that STS may play a
critical role in the severity hormone dependent cancers and their long-term outcomes.
Evidence suggests the sulfation and thus deactivation of steroid hormones may be down
regulated in cancer cells however, the activity of STS is frequently seen in many tumor
types (Mueller et al., 2015). This indicates that in these tissues alterations to the sulfation
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pathway may be occurring in a manner that favors the downstream conversion and
activation of steroid metabolites and can lead to increased tumor growth and malignancy.
In patients being treated for hormone-dependent breast cancers the activity of STS can be
upwards of 200-fold higher than in healthy tissues (Mueller et al., 2015). Furthermore,
when compared to aromatase, STS has increased levels of mRNA expression in breast
tumors that would suggest that STS is the preferential mode of local E1 synthesis in these
types of cancers (Mueller et al., 2015).
The elevated levels of STS in breast tumors are also strongly associated with the
histological grade of a tumor, as well as potential lymph node metastasis, and overall
poor prognosis of patients (Mueller et al., 2015). STS also plays an important role in the
biological synthesis of androgens and estrogens in the prostate. However, unlike breast
cancer, malignancy of prostate tissue is not correlated with an increase in the levels of
circulating estrogens (Mueller et al., 2015). In patients being treated for prostate cancer
using enzalutamide or abiraterone, both inhibitors of steroidogenesis, serum levels of
both dehydroepiandrosterone sulfate (DHEAS) and biologically active DHEA remain
high regardless of antiandrogen treatments (Armstrong et al., 2020). While STS is found
in relative abundance in normal prostate tissue it is, as with breast cancers, the alterations
in expression and activity of STS that plays a role in the overall development of a
malignancy (Farnsworth, 1973). As with breast cancers, STS mRNA is frequently found
at higher levels and enzymatic activity is found to be elevated, both factors leading to
increased risks of metastasis as well as poor overall outcome (Mueller et al., 2015).
Overall, existing evidence suggests that sulfation of steroids plays an important in
regulation of biological functions.
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CHAPTER III

Comparison of sulfation pathway enzymes and transporters in GnRHR-II
knockdown and littermate control boars

Abstract

Pigs are the only species of livestock that produce the second isoform of gonadotropin
releasing hormone (GnRH-II) and its corresponding receptor (GnRHR-II). Our laboratory
has produced a line of knockdown (KD) swine in which GnRHR-II production is reduced
by approximately 70%. Furthermore these animals have a primary hypogonadism
phenotype resulting is drastic reduction of circulating testosterone of 82% in reference to
control littermates. Paradoxically, these KD swine do not show any differences in
luteinizing hormone (LH) levels, which would indicate that reduced testosterone
secretion is occurring independently of LH signaling. Previous mass spectrometry
analysis of circulating hormone profiles, we reported that serum progestogens (17αhydroxyprogesterone and progesterone), androgens (DHEA, DHT, and androsterone) and
estrogens (17β-estradiol) were all reduced (P<0.05) in the knockdowns compared to
controls. As well as a tendency for reduction for circulating testosterone, DHEA-S, and
androstenedione (P≤0.1). However, when the same panels were evaluated using testicular
homogenates there were no differences found in steroid concentrations between the
GnRHR-II KD and their control littermates.
The objective of this study is to evaluate one potential cause for the aberration we
see between circulating steroid concentrations and concentrations within tissue. The
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sulfation pathway, or sulfoconjugation, is a Phase II metabolic reaction involving the
addition of a sulfate group onto a compound. Sulfation has gone predominantly
overlooked. Evidence over the last twenty years has suggested that this reaction may play
a larger role in steroid homeostasis. Previous publications have demonstrated that swine
produce high concentrations of sulfated steroids and have elevated levels of pathway
participants within the testes. To the best of our knowledge, this is the only data
regarding sulfation pathway enzymes and transporters with relation to reduced GnRHR-II
expression in swine. Porcine primers (ABCC1, STS, PAPSS, OSCP1, SULT2A1, and
SULT1E1) were used in a droplet digital PCR assay with EvaGreen® to detect target
genes using absolute quantification. Results indicate that of the genes evaluated using this
method, there was no difference between GnRHR-II knockdown boars and their control
littermates (P>0.05). From this, we determine that the sulfation pathway is not the source
of differential steroid concentrations and provide the first known descriptions of PAPSS,
ABCC1, and OSCP1 presence in porcine testis. Due to current evidence in the literature
further investigation is necessary to understand the role of sulfation in the GnRHR-II KD
phenotype

80

Introduction

Subfertility in boars poses an economic risk to producers but is often overlooked
compared to gilt and sow parameters as identification of subfertile boars is difficult to
detect until sexual maturity (Ruiz-Sánchez et al., 2006). Commonly the swine industry
frequently pools semen from multiple boars in order to mask the impact of subfertile
boars, which requires the housing of extra animals and slows the genetic progress of
herds (Xu et al, 1998). As such, alternative methods of identifying low quality animals is
necessary to improve the reproductive efficiency of boar studs.
GnRH is classically regarded as the primary regulator of reproduction via the
HPG-axis. Following synthesis within GnRH neurons in the hypothalamus, this
decapeptide hormone is secreted from the median eminence into the hypophyseal portal
and circulated to the anterior pituitary. Here it binds to its receptor on gonadotropes and
facilitates the release of FSH and LH that then travels to the gonads and stimulate the
release of sex steroids. Yet GnRH is not the only form of gonadotropin releasing
hormone that is known. GnRH-II was first identified in chickens but has since been
identified in more than 80 mammalian species (Miyamoto et al., 1984; Millar, 2005;
Desaulniers et al., 2017). This form of GnRH and its receptor (GnRHR-II) differ from
GnRH-I and GnRHR-I both structurally and in tissue localization (White et al., 1998;
Tensen et al. 1997; Basith et al., 2018). However, most mammalian species have nonfunctional genes for this alternate ligand and receptor, owing to coding errors such as
frameshifts and deletions (Neill et al., 2002; Stewart et al., 2009). Of the limited species
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that do encode functional proteins for both GnRH-II and GnRHR-II, pigs are the only
livestock species (Millar, 2005; Desaulniers et al., 2017). This makes pigs an optimal
model to investigate the biological role of the receptor-ligand complex, as well as being a
better human comparison than mice owing to closer biological parameters and genome
sequence (Walters and Prather, 2013).
To that extent, our laboratory designed a transgenic knockdown model using
small hairpin RNA (shRNA) to reduce the relative expression of GnRHR-II by 70% in
comparison to their littermate controls (Desaulniers et al., 2017). Radioimmunoassay of
serially collected serum samples found that while there was an 82% reduction in
circulating testosterone there was no difference in LH levels between lines. From this, it
was concluded that this ligand-receptor complex was participating in LH independent
production of testosterone. Furthermore, since both the receptor and ligand are found at
their highest concentrations within the porcine testis it was suspected that there may be
some form of autocrine/paracrine regulation of steroidogenesis occurring. In previous
studies using mass spectrometry, we determined that GnRHR-II knockdown boars exhibit
decreased levels of progesterone, 17α-progesterone, androstenedione, DHEA, DHEA-S,
estrone, estradiol, 11-deoxycortisol, dihydrotestosterone, androsterone and testosterone in
circulation compared to controls (Desaulniers et al., 2017). However, upon comparison to
testicular samples there was no difference seen in steroid concentrations between the
knockdown boars and their control littermates (Desaulniers et al., unpublished data). A
potential cause of this that we proposed could account for the difference between
circulation and tissue concentrations is sulfoconjugation.
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Sulfoconjugates of biomolecules were initially described in 1876 as waste products of
metabolic activity found in urine of horses (Baumann, 1876). Since then they have been
identified as one of the most common types of biomolecules, found ubiquitously
throughout organisms and are necessary for a broad spectrum of critical biological
functions (Mueller and Shafqat, 2013). Recent insights into their reproductive role
suggest that sulfates participate in steroid homeostasis (Geyer et al., 2017) and unlike
glucuronides, sulfates are a reversible reaction (Schiffer et al., 2019). Evidence also
indicates that malfunctions in the sulfation pathway lead to complications in fertility and
steroid dependent cancers (Sánchez-Guijo et al., 2016). Steroid sulfoconjugates have
increased water solubility and longer half-lives compared to biologically active steroids
(e.g. DHEA: 15-30 minutes, DHEA-S: 7-10 hours; White and Porterfield, 2012). Due to
the presence of high concentrations of steroid sulfates and for greater levels of activity of
enzymes within the sulfation pathway, swine provide an optimal model to investigate
sulfoconjugation (Mutembei et al., 2009). Given the aberration between circulating
steroid and tissue steroid concentrations we hypothesized that these differences were
because of altered steroid sulfation or transport within the testis.
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Method and materials

Animals. Animal procedures were performed using standard production and
experimental practices in accordance with the Guide for the Care and Use of Agricultural
Animals in Research and Teaching with approval by the University of Nebraska –
Lincoln (UNL) Institutional Animal Care and Use Committee (IACUC). This study used
mature (>300 d of age) GnRHR-II KD swine, representing 7 different litters, raised as
previously described (Desaulniers et al., 2017). Adult boars were housed individually, in
pens or crates, and provided with ad libitum water and approximately 2.5 kg of feed daily
until time of necropsy.
RNA isolation. Gene transcripts were evaluated in mature boar (>300 d of age)
testiticular tissue. Once excised, the testis is trimmed and weighed then split
longitudinally. Using tools that had been cleaned with RNase Away (MP Bioproducts
#7002) 1cm3 sections of testis tissue were isolated from the parenchyma and placed into
micro-centrifuge tubes of RNALater (Invitrogen #AM7020). Samples were stored at 4°C
overnight for precipitation then moved to -20°C until extraction. To extract RNA,
samples were placed into a crucible, liquid nitrogen poured over, and tissue crushed
finely with pestle. Sample was combined with 1mL TRI Reagent® (Thermo #15596026)
in a micro-centrifuge tube and topped with 200µL chloroform (Fisher #14-650-505) then
vortexed for 10-15 seconds. All samples were the centrifuged (1,600 x g, 2 minutes, room
temperature) and the aqueous layer was transferred to new tube. Isopropanol (600µL)
was added to each sample, which were then incubated at -20°C overnight. Tubes were
then centrifuged (1,600 x g, 20 minutes, 4°C) and supernatant discarded. Pellet washed
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with 75% ethanol and centrifuged again (1,600 x g, 10 minutes, 4°C) then the supernatant
discarded and pellets allowed to dry on benchtop before being suspended in nuclease-free
water. The concentration and quality of RNA samples were quantified using a Take-3
plate with an Epoch Spectrophotometer System (BioTek, Winooski, VT, USA) to certify
all samples had a 260/280 ration of 1.9-2.2. RNA isolates were reverse transcribed to
cDNA using the iScript cDNA kit (Bio-Rad #1725034) with a genomic DNA pretreatment. Samples were diluted 1:100 and 1:1000 then stored at -20°C.
Primer Design. Primers to evaluate sulfoconjugation (SULT2A1, SULT1E1,
PAPSS, STS, ABCC1, and OSCP1; Table 2) were designed for ddPCR specific to the
EvaGreen (Bio-Rad, Hercules, CA, USA) Supermix based assay using the Primer Blast
(Ye et al., 2012) system according to the recommended criteria. Primers were purchased
through Integrated DNA Technologies (IDT; Coralville, IA, USA) and re-suspended in
nuclease free water to a stock concentration of 100µM. Forward and reverse primers
working solutions were then made at a concentration of 10µM, both the stock and
working concentrations were then stored at -20°C. gBlock® gene fragments were also
purchased from IDT then diluted to 10ng/mL and the copies/µL determined using the
molecular weight and fmol/ng conversions provided by IDT then diluted to ~3,500
copies/µL which was then stored at -20°C.
mRNA Quantification. Droplet Digital PCR (ddPCR) was performed using the QX200
system (Bio-Rad). A 2X concentration of EvaGreen Supermix (11µL) was added to a
semi-skirted, colorless 96-well PCR plate (Eppendorf). 10µM working solution of IDT
primers (0.22µL) was added to individual wells along with 10µL of 1:100 cDNA sample.
The total volume of the wells was then brought up to 22µL using nuclease free water.
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gBlock® gene fragments (IDT) were used for positive controls for expression of target
transcripts and nuclease-free water was used as a negative control. Plate was covered
with adhesive film (VWR) then vortexed and centrifuged (3,000 x g, 1 minute, room
temperature) prior to generating approximately 20,000 droplets using a QX200 Droplet
Digital Generator (Bio-Rad). Droplets were then transferred to a ddPCR 96-well plate
(Bio-Rad) compatible with the QX200 system then heat-sealed and thermocycled on a
C100 Touch Thermo Cycler (Bio-Rad). Cycling conditions were set according to the
annealing temperature of the designed primers and the ramp rate was set to 1°C/second.
Quantification of transcripts was performed using a QX200 Droplet Reader (Bio-Rad)
and results were analyzed using QuantaSoft Analysis Pro Software (Bio-Rad).

Statistical Analysis. Statistical analysis was performed using the Statistical
Analysis System (SAS; version 9.4; Cary, NC). Expression of SULT2A1, SULT1E1,
PAPSS, STS, ABCC1, and OSCP1 mRNA analyzed by ddPCR were calculated as the
number of transcript copies of target gene per µL normalized to the number of transcript
copies of the reference gene BACTIN (β-actin) per µL. Messenger RNA expression of
sulfate pathway enzymes and transporters data were analyzed for effects due to line by
ANOVA using the Mixed procedure of SAS. The statistical model included line
(GnRHR-II KD or control) as the fixed effect with litter as a random effect. Animal was
the designated experimental unit. For all analyses, a P-value ≤ 0.05 was considered
significant and a P-value of ≤ 0.10 was considered a tendency. All results are presented
as lease squares means (LSMEANS) ± the standard error of the mean (SEM).
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Results and Discussion

Here we provide, to the best of our knowledge, the only descriptions extant of sulfation
pathway enzymes and transporters in relation to GnRHR-II functionality. Sulfation was
originally considered metabolic waste products following their discovery in horse urine
(Baumann, 1876). However, over the last few decades scientific opinion has shifted as
new insights were made. It is now known that sulfates participate in a broad range of
critical functions (Mueller and Shafqat, 2013). In particular, this pathway has growing
implications as a regulator of steroidogenesis and biologically active steroids. Sulfated
steroids can be found in circulation at levels much higher than their free counterparts,
such as in the case of DHEA-S and estrone sulfate which are frequently measured at
100X and 20X times higher respectively (Pasqualini, 2004). Furthermore,
sulfoconjugation is a reversible reaction, where as other metabolic products (e.g.
glucuronides) are not, meaning that steroid sulfates can be reactivated in tissues possess
steroid sulfatases (Schiffer et al., 2019).
Enzymes and transporters involved in the sulfation pathway have previously been
described within boar testis (Mutembei et al., 2009; Schuler et al., 2014; Schuler et al.,
2018; Schuler et al., 2018). Given the lack of SHBG in swine (Aydin et al., 2016), this
pathway also provides a potential solution for steroids in circulation as the presence of
sulfate increases the water solubility to the point where free circulation is possible (e.g.
DHEA-S; Schuler et al., 2014).
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Furthermore, pigs are the only known livestock species to possess functional
copies of both GnRH-II and GnRHR-II. We have demonstrated previously that this
receptor ligand complex exists at its highest concentration outside of the brain,
particularly within the testis of swine (Desaulniers et al., 2015). We developed a GnRHRII knockdown model for further describing the biological function of GnRH-II and its
receptor in swine. These transgenic boars express approximately 70% less GnRHR-II
mRNA than their control counterparts (Desaulniers et al., 2017). Serial blood collection
and mass spectrometry analysis of serum hormone profiles of these animals found the
knockdown boars had a drastic reduction in steroid hormones originating from the testis
(Desaulniers et al., 2017). Paradoxically, when hormone profiles of testicular tissue was
also evaluated with mass spectrometry we found that there was no difference between the
GnRHR-II knockdown boars and their control littermates (Desaulniers et al., unpublished
data).
We chose to focus on this pathway because of increased interest in sulfation as an
alternative method of steroid homeostasis (Geyer et al., 2017), the high presence of
steroid sulfates in swine (Mutembei et al., 2009), and because sulfates are not typically
analyzed in standard mass spectrometry profiles (Schuler et al., 2018). We performed
digital analysis of enzymes and transporters that have previously been described in swine
and are primary regulators of sulfation, including a rate-limiting enzyme. We found there
was no statistical difference in expression between the GnRHR-II knockdowns and their
littermate controls for any of the genes analyzed. This was, to some extent, expected for
PAPSS (P = 0.3687; Figure 14C) as it is rate-limiting step of sulfation and PAPS itself
acts as a universal sulfate donor for multiple biological systems beyond steroid
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conjugation. Changes to expression can result in multiple pathologies that such as
cartilage deformities and brachymorphism (Paganini et al., 2020). There was no
difference seen in STS (P = 0.3610; Figure 14D) expression which could indicate that
we should also include other tissues (e.g. epididymis and prostate) to further characterize
this enzyme in knockdown swine as the testis is not the only target tissue of steroids. In
previous studies we have shown that the weight of the prostate tended to be reduced (P =
0.0986) and penis weights were reduced (P = 0.0319) GnRHR-II KD boars compared to
littermate controls (Desaulniers et al., 2017). However, we were expecting at least
SULT2A1 (P= 0.3511; Figure 13A) or SULT1E1 (P= 0.8489; Figure 13B) to show
some difference as we do see reduced DHEA-S (P ≤ 0.1) in our mass spectrometry
analysis of serum steroid concentrations which would suggest alterations to these
enzymes. This was one of the reasons suggested as to why there was a difference between
serum and tissue concentrations of steroids between GnRHR-II and control boars. The
transporters ABCC1 (P = 0.5461; Figure 14A) and OSCP1 (P = 0.9819; Figure 14B)
prove equally as interesting for their lack of difference. Given the higher water solubility
of steroid sulfates, transporters are necessary for movement into circulation. Though
these data suggest that GnRHR-II KD swine do not have altered transport, unlike SULTs,
there is far less description of substrate specificity for transporters. This could be
investigated by including other transporter members with sulfate specificity that have
been identified (i.e. OATP6A1 or SOAT). These data suggest that sulfation and sulfate
transport does not differ between the GnRHR-II KD and control boars. However, given
the high level of individual variance seen and the average difference seen in some
transcripts (e.g. SULT2A1 and ABCC1) we believe there is still potential in this pathway
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as target of interest. The next steps for investigation would include mass spectrometry of
serum and urine samples for sulfate conjugate concentrations as well as testicular culture
with agonist and antagonists of this pathway. While expression of these transcripts may
not differ it is possible that enzyme activity is different. The sulfation pathway could also
present a potential target to rescue the hypogonadism phenotype of GnRHR-II KD boars.
This could be explored by the use of in vivo and in vitro agonists for STS with the
intention of increasing the availability of free steroid hormones.
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Table 3. ddPCR porcine primer sequences for sulfation pathway
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Figure 13 Relative mRNA levels in testicular tissue of GnRHR-II KD (n=13) and
control littermates (n=11) boars. Values normalized to β-actin levels. Data are
presented as the LSMEANS ± SEM. (A) Sulfotransferase2A1 enzyme (P= 0.3511).
(B) Sulfotransferase1E1 enzyme (P= 0.8489)
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Figure 14. Relative mRNA levels in testicular tissue of GnRHR-II KD (n=13) and
control littermates (n=11) boars. Values normalized to β-actin levels. Data are
presented as the LSMEANS ± SEM. (A) Steroid sulfate exporter ABCC1 (P =
0.5461). (B) Steroid sulfate importer OSCP1 (P = 0.9819). (C) PAPSS (P = 0.3687).
(D) STS (P = 0.3610).
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CHAPTER IV

Differentially expressed genes within the testicular transcriptome of GnRHR-II
knockdown boars

Abstract

Swine are the only known livestock species that retain functional genes for the second
type of mammalian gonadotropin releasing hormone (GnRH-II) and its corresponding
receptor (GnRHR-II). Recent studies have found that GnRH-II is not likely to induce
secretion of gonadotropins in vivo, but rather stimulate steroidogenesis directly at the
testis via autocrine/paracrine signaling. To explore the function of GnRH-II and its
receptor within the testis, our laboratory produced a transgenic line of GnRHR-II
knockdown (KD) swine paired with florescent ZsGreen co-expression. Digital droplet
PCR (ddPCR) analysis determined that transgenic males had a reduced expression of
GnRHR-II by 70% along with hypogonadism. Despite normal levels of luteinizing
hormone, circulating levels of evaluated gonadal steroids (estrogens, progestogens, and
androgens) are depressed 60-98%. These data indicate that steroidogenesis within the
testis is being critically regulated by the GnRH-II ligand-receptor complex independently
of traditional gonadotropin signaling although the molecular and cellular mechanisms of
this pathway remain unelucidated. Further analysis was then performed through RNA
sequencing to evaluate the testicular transcriptome of mature (>300 d) GnRHR-II KD
swine (n=10) and control littermates (n=7). Genes and transcripts were considered to be
differentially expressed at a false discovery rate (FDR) adjusted P-value ≤ 0.05. Read
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mapping described 81,209 transcripts (44,028 previously annotated and 37,181 novel)
and 22,143 matching porcine genes identified within the testis. Of these, 74,496
transcripts were determined to be protein coding while 6,713 were noncoding along with
1,843 novel noncoding transcripts (lncRNA) and 76 novel mRNA transcripts were
identified. Altogether, it was determined that there were 95 differentially expressed
transcripts between GnRHR-KD littermate control testes –4 novel lncRNAs, 56 novel
mRNA transcripts, and 35 described transcripts. We determined the presence of 24
differentially expressed genes (DEG) of which 6 were novel and the other 18 had been
previously annotated within the Sscrofa reference genome. Between lines, there were 11
DEGs down-regulated and 13 DEGs up-regulated within the testicular transcriptome.
Down-regulated genes included GnRHR-II along with genes related to spermatogenesis
(LOC106504199), differentiation (EGR1, FIBIN, MSI1), adhesion (THBS1, CNTN1),
and cell signaling (GUCY1A3). Putative functions of up-regulated genes include
enzymes within the ubiquitination pathway (UBE2W, USP42), protein binding
(MORN4), lipid metabolism (ABHD18), and mitochondrial function (LOC100524239).
There were no DEGs identified that were involved with classical, LH-mediated
steroidogenesis, which would indicate that GnRHR-II KD does not alter steroidogenesis
by down-regulating traditional means of synthesis. Further exploration in to the roles and
functions of both GnRHR-II and the identified DEGs of the porcine transcriptome could
be used to optimize fertility in boars.
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Introduction

Classical steroidogenesis under the control of gonadotropin releasing hormone (GnRH) is
considered the primary regulator of reproduction via the stimulation of luteinizing
hormone (LH) and follicle-stimulating hormone (FHS). Additionally, a second
structurally unique form of GnRH (GnRH-II; His5, Trp7, Tyr8) has also been identified
within mammals and interestingly has its highest concentrations outside of the brain
(King et al., 1989). A complementary receptor, GnRHR-II, was also identified and
described in mammals (Millar et al., 2001) and we determined that localization is also
highest outside the brain. Among the small number of mammalian species that have
functional genes for GnRH-II and GnRHR-II, swine are the only livestock species, which
makes them an ideal model for study. We have previously determined that both GnRH-II
and GnRHR-II are produced at significantly higher concentrations within the testis as
opposed to other tissue types (Desaulniers et al., 2017). This would suggest that GnRH-II
and its receptor play a role in some autocrine/paracrine function within the testicular
compartment. It was determined that GnRHR-II and its receptor are critical for regulation
of steroidogenesis within swine and constitute novel potential molecular targets in boar
fertility.
To investigate the biological function of this ligand-receptor complex, our
laboratory developed a pig model with a 70% reduction in functional GnRHR-II
(Desaulniers et al., 2017). These transgenic boars exhibited an 82% reduction in
testosterone with no detected changes in the circulating LH concentrations (Desaulniers
et al., 2017). Furthermore, these same animals had reductions other examined gonadal
steroids along with lower overall body weights and the weights of androgen-sensitive
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organs. Given the broad impact of GnRHR-II reduction on the levels of steroidogenesis
and overall tissue function, here we endeavored to describe the potential impact of
GnRHR-II on testicular gene expression.
In this study we have performed isolation and sequencing of RNA transcripts
from a group of mature (>300 d age) GnRHR-II KD boars along with control littermates
for comparison. The aim of this study is to identify differentially regulated genes in the
testicular transcriptome of our knockdown boars and determine potential targets of
downstream GnRHR-II regulation. By doing so we endeavor to describe both the overall
transcriptome of the GnRHR-II knockdown and to pinpoint potential targets to improve
boar fertility.
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Method and Materials

Animals.

All animal procedures were performed using the standard

production and experimental practices according to the Guide for the Care and Use of
Agricultural Animals in Research and Teaching with approval by the Institutional Animal
Care and Use Committee (IACUC) of the University of Nebraska – Lincoln (UNL). All
utilized animals were raised as described previously (Desaulniers et al., 2015) and only
mature animals (>300 d of age) were used. Boars were housed individually, in crates or
pens, and fed approximately 2.5 kg daily with ad libitum water until time of necropsy.

Processing RNA sequencing (RNA-seq) data.

The quality of individual

fastq files for each library was assessed using FastQC (Version 0.11.5;
www.bioinformatics.babraham.ac.uk/projects/fastqc). Low quality bases were trimmed
and adapters were removed using Trimmomatic software (Version 0.35; Bolger et al.,
2014). The trimmed reads were mapped to Sscrofa 11.1 genome assembly (NCBI
accession GCF_000003025.6) using Hisat2 with default parameters (Version 2.1.0; Kim
et al., 2015). The mapped transcripts were assembled for each library using Stringtie
(Version 2.1.3b; Pertea et al., 2015) with the help of Sscrofa 11.1 reference annotation
(NCBI release 106). Finally, a consensus set of transcripts were generated by merging all
the transcripts from each library using Stringtie merge option.
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Identification and characterization of novel transcripts. Initial filtering of
transcripts was based on the level of expression measured as fragments per kilobase of
exon per million mapped reads (FPKM). Transcripts with FPKM < 0.3 and transcripts
expressed in a single sample were filtered out (Cai et al., 2018). Selected transcripts were
compared to Sscrofa reference annotation (NCBI release 106) using gffcompare (Version
0.11.1; Pertea and Pertea, 2020). Transcripts with gffcompare class code “=” were
considered overlapping with known transcripts in the reference annotation while
transcripts with class codes “i” (fully contained within a reference intron; ilncRNA), “j”
(multi-exon with at least one junction match to a reference transcript; isolncRNA), “x”
(exonic overlap on the opposite strand; lncNAT) and “u” (unknown intergenic; lincRNA)
were considered potential novel transcripts (Cai et al., 2018).
Putative novel transcripts were subjected to several additional filtering steps as
outlined in Cai et al. (2018). Transcripts with length  200 bp and number of exons  2
were selected for further filtering (Figure 15). The open reading frames (ORF) were
obtained for filtered transcripts using TransDecoder (Version 5.5.0;
https://github.com/TransDecoder/TransDecoder/wiki). Transcripts without a predicted
ORF were filtered out and transcripts with ORF length  120 amino acids were
considered protein coding. The protein coding potential for transcripts with ORF length <
120 amino acids were assessed using CPC2 (Version 2.0; Kang et al., 2017), PLEK
(Version 1.2; Li et al., 2014), and CNIT (Guo et al., 2019). Additionally, the HMMER
(Version 3.3.2; Finn et al., 2011) was used to search for known protein coding domains
against the pfam database (release 34; Finn et al., 2016). Transcripts with CPC2
classification “coding”, PLEK score > 0, CNIT > 0, and significant pfam hits (E-value <
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10.0) were classified as protein-coding (mRNA), while transcripts with CPC2
classification “noncoding”, PLEK score < 0, and CNIT score < 0, and no significant pfam
hits were classified as long noncoding RNA (lncRNA). All the other transcripts, where
the diagnosis was not consistent among the programs were discarded as their coding
potential was ambiguous.
The homology between novel lncRNA and the NONCODE database (swine and
other species) was assessed using NONCODE (Version 6.0;
http://www.noncode.org/blast.php) Blast option. The novel mRNA sequences were blast
against the NCBI Non-redundant Nucleotide database (nt; Version 5
https://ftp.ncbi.nlm.nih.gov/blast/db/) using BLASTN option. Both NONCODE and
BLASTN were run using E-value cutoff of 10.0 to define homology between sequences.

Differential expression and gene pathway analyses.

The number of reads

mapped to 81,209 transcripts and 22,143 corresponding genes was calculated using
StringTie. The raw read counts were normalized and differential expression of transcripts
and genes were analyzed using DESeq2 (Version 1.26) using a generalized linear model
and a negative binomial distribution to model transcript read counts and shrinkage
estimators (Love et al., 2014). The analysis was done comparing transgenic boars to
control boars (transgenic versus control boars) using DESeq2 default parameters. A
transcript or a gene was considered differentially expressed at FDR-adjusted P value ≤
0.05.
Presence of differentially expressed genes (DEG) in cell signaling pathways and
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gene networks were evaluated using iPathwayGuide software (Version 1910; Advaita
Bio, http://advaitabio.com/ipathwayguide). Analysis was performed using Homo sapiens
as the reference dataset. The over-representation of DEG in a given pathway and the
perturbation of that pathway were combined into an overall pathway score by calculating
a P value using Fisher’s method. A pathway was considered significant at FDR-adjusted
P value ≤ 0.05. The gene ontologies (GO) were obtained using an over-representation test
by comparing the number of DEG annotated to the GO term and the number of DEG
expected by chance. The statistical significance was calculated using a hypergeometric
distribution and a GO term was considered statistically significant at FDR-adjusted P
value ≤ 0.05.
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Results and Discussion

Identification of novel transcripts
RNA libraries generated approximately 1 billion paired-end reads that had a
length of 75 base pairs, and the libraries used averaged 71.4 million raw reads (Table 4).
Between the lines there were approximately 66.6 million reads that were mapped to the
Sscrofa genome assembly that had 93.2% mapping efficiency per library on average.
Control boars had reads ranging from 51.2-90.3 million while the GnRHR-II knockdown
boars reads had a range of 53.4-84.3 million. Transcripts were evaluated using their ORF
length to determine their potential as protein coding. Typically it is difficult to distinguish
between coding and non-coding transcripts an ORF  120 amino acids in length is
considered as a threshold (Cai et al., 2018). This method identified a total of 81,209
transcripts in the boar testes; 37,181 novel and 44,028 that had been previously annotated
(Figure 15). These transcripts correspond to 22,143 genes (1,419 novel and 20,724
annotated), also novel lncRNA transcripts can be matched to 1,267 genes and with novel
mRNA transcripts corresponding to 9,591 genes, which have 795 and 8,493 previous
annotations respectively.
Novel lncRNAs were classified as having 438 novel isoforms (isolncRNA), 672
intergenic transcripts (lincRNA), 367 intronic transcripts (ilncRNA), and 366 transcripts
that flank a protein coding gene on the antisense strand (lncNAT; Figure 16). These
transcripts were then evaluated using the NONCODE database to compare the homology
of the novel lncRNA to swine and other species using NCBI BLAST. It was determined
that 313 of these transcripts share homology with NONCODE swine transcripts and 337
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lncRNA were homologs to other species NONCODE database (Figure 17). Homology of
mRNA transcripts was also evaluated using NCBI BLAST, which identified 2,743
transcripts homologous to swine, 860 with homology to other species, and 30, 498
transcripts that had shared homology with both swine and other species (Figure 18).
It was determined that there were 95 differentially expressed transcripts (DETs)
that were comprised of 35 known transcripts, 4 novel lncRNA, and 56 novel mRNA .
From these 24 differential genes (DEGs; Table 5) were described, 6 novel genes and 18
genes that had been previously annotated in the Sscrofa referene genome. The putative
functions of the known genes involved spermatogenesis, cell growth/differentiation, cell
signaling, transcriptional regulation, cell adhesion. Ubiquitination, mitochondrial
function, immune response, lipid metabolism, and protein binding. The broader functions
and available literature are discussed in greater detail below.
Spermatogenesis.
FAM24A-like (LOC106504199).

Family with Sequence Similarity 24

Member A-like protein has not been fully described and its function has yet to be fully
elucidated. The coding sequence has been identified on pig chromosome 14 in a region
contained in close proximity to the gene for Deleted in Malignant Brain Tumor 1
(DMBT1; Ambruosi et al., 2013). DMBT1 has been found to be present in the oviduct of
both pigs and horses, and has been demonstrated to be involved in sperm-negative
selection (Ambruosi et al., 2013; Treijeiro and Marini, 2012). Furthermore, the DMBT1
locus of mice, rats, cows, dogs, and chimpanzee also contain the gene for FAM24A-like,
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which suggests that they may have similar roles as described in the pig (Ambruosi et al.,
2013)

Cell growth/differentiation
Early Growth Response 1.

EGR1 (also called KROX24, NGFIA, ZIF268) is a

mammalian transcription factor that belongs to the EGR family of zinc finger proteins
(Knapska and Kaczmarek, 2004) that is necessary for the activation of target genes for
differentiation and mitogenesis (Stallings et al., 2016). It was initially identified in the
mid-1980s and contains a DNA-binding domain with three zinc-finger motifs
(Millbrandt, 1987). Evidence suggest that Egr-1 is a critical regulator of gonadotropes
(Tremblay and Drouin, 1999) by stimulating the expression of luteinizing hormone β
(LHβ). Egr-1 knockout mice have a reduction in overall body size and infertility in both
sexes (Lee et al., 1996; Topiko et al., 1998). In perifused murine LβT2 gonadotrope cells,
it was shown that there is a promoter for Egr-1 (-53/-37 bp) upstream of the AMH
receptor type 2 (AMHR2; Garrel et al., 2018). siRNA mediated knockdown of Egr-1
resulted in reduced AMHR2 promoter activity and it was shown that co-expression of
Egr-1 and SF-1 are necessary for basal promoter function (Garrel et al., 2018; Wolfe and
Call, 1999). Egr-1 and specificity protein 1 have also been determined to be crucial
regulators of the Dmtr-1 gene within Sertoli cells (Lei and Heckert, 2002) which is
necessary for testis development and sex differentiation in many mammalian species
(Huang et al., 2017). Our laboratory has determined the presence of overlapping Egr-1
and specificity protein 1 and 3 (SP1/3) binding sites upstream of the porcine GnRHR-II
promoter are necessary for basal levels of promoter activity (Brauer et al., 2016). From

107

this, we concluded that Egr-1, SP1, and SP3 act as gene regulators in response to
differing cellular environments.
Fin bid initiation factor homolog.

FIBIN is a novel secreted protein found to

be present in zebrafish, mice, and humans (Wakahara et al., 2007). Zebrafish embryos
injected with an anti-sense FIBIN morpholino were found to have no expression of Tbx5,
a T-box transcription factor that is exclusively expressed during forelimb development
(Ng et al., 2002), and as a result completely lacked pectoral fin buds (Wakahara et al.,
2007). These findings indicate that FIBIN induces the expression of Tbx5, although the
signaling cascade is still unknown. FIBIN mRNA has also been found to be expressed at
increased levels of neonatal mice born with X-linked nephrogenic diabetes insipidus
(Schliebe et al., 2008). qPCR studies of different stages of mouse embryos found that
expression of FIBIN was highest in the cerebellum, skeletal muscle, and trunk of
embryos at 13-16 days post fertilization (Lakner et al., 2011). While FIBIN is at its
highest expression in fetal tissues, it is found to be present at low levels in adult tissues
(testis, ovary, lung) indicating other roles beyond embryogenesis (Lakner et al., 2011). In
mice with ovariectomy-induced sarcopenia, it was found that FIBIN has a binding
sequence for the micro-RNA MiR-141-3p that reduced its expression and led to increased
mitochondrial dysfunction and muscle atrophy (Lee et al., 2021).
Musashi RNA binding protein.

This RNA-binding protein (MSI2) has been

shown in recent years to play important roles especially in differentiation. In embryonic
stem cells, MSI2 has been linked to expression of SOX2, which is necessary for the stem
cell renewal (Wuebben et al., 2012). While it has been known that Musashi binding
proteins play a role in the formation of the central nervous system (CNS; Sakakibara,
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2002) there is increasing evidence that MSI2 also plays a broader role in reproduction as
well. Screening of genes involved in germ cell biology of Drosophila identified MSI
proteins as critical for the regulation of meiosis and testicular germ cell maintenance
(Siddall et al., 2006). In a line of MSI2 null mice, designed to examine the binding
proteins role in hematopoiesis, null mice were found to be smaller than wild-type
counterparts as well as producing smaller litters and exhibiting infertility when bred
together (de Andrés-Aguayo et al., 2011).
Both Musashi family members have been found to be present within the testis of
mammals, although localization differs. MSI1 is localized to gonocytes and
spermatogonia whereas MSI2 is detectible only with in meiotic spermatocytes and
differentiating spermatids (Sutherland et al., 2014). While MSI2 is expressed in both
germ cells and somatic cells, it is necessary for the intrinsic maintenance of stem cell
identity (Siddall et al., 2006). Loss of function of either MSI1 or MSI2 is detrimental to
normal spermatogenesis (Sutherland et al., 2014) and MSI2 deficiency results in an
embryonic lethality phenotype of 50% (de Andrés-Aguayo et al., 2011). The role of
Musashi in female tissues is far less defined than in the testis. However, it has been
shown that MSI2 deficient mice have ovaries that are 41% smaller than wild-type
controls as well has having a significant reduction in antral follicles (Sutherland et al.,
2015). While the ovarian function of MSI2 is still being fully evaluated, it was concluded
that this binding protein is necessary for normal folliculogenesis (Sutherland et al., 2015).
Cell signaling.
Guanylate cyclase 1 soluble subunit alpha 3.

GUCY1A3 encodes for

soluble guanylate cyclase (sGC), which is a heterodimer enzyme that catalyzes the
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conversion of GTP to cGMP (Kessler et al., 2017). Cyclic GMP (cGMP) has been well
documented as a regulator of cellular apoptosis (Lee et al., 2019), ion channels (McCoy
et al., 1995), glycogenolysis (Borgs et al., 1996), as well as playing a key role in the
sexual arousal response in both male and female genitalia (Kim et al., 2004). In the testis,
cGMP has been indicated as a secondary messenger in c-type natriuretic peptide
signaling in Sertoli cells (Yu et al., 2021) and as part of the regulatory signaling for
Sertoli-germ cell adherens junctions (Lee et al., 2005) and spermatogenesis (Lee and
Cheng, 2008). Rats expressing hypogonadotropic hypogonadism treated with exogenous
testosterone showed increased NO-cGMP signaling (Andric et al., 2010). It has also been
found that aging has a positive correlation with expression of GUCY1A3 and other genes
responsible for cGMP production (Baburski et al., 2017). Furthermore, the increase of
cGMP seen with aging has also been linked to reductions in mitochondrial function and
impaired steroidogenesis (Sokanovic et al., 2021).
Transcriptional Regulation.
Poly(U) binding slicing factor 60.

PUF60 is a DNA and RNA-binding protein

that was first described in 1999 (Page-McCaw, 1999) with a variety of roles including
RNA splicing (Hastings et al., 2007), apoptosis (Matsushita et al., 2006), and
transcriptional regulation via suppression of TFIIH (Liu et al., 2000; Liu et al., 2001).
PUF60 was also identified as an elevated autoantibody marker for gastrointestinal
cancers (Kobayashi et al., 2018), which supports other evidence indicating that PUF60 is
a critical spliceosome member in carcinoma growth. PUF60 has been found to be an
important RNA-binding protein in breast (García-Cárdenas et al., 2022; An et al., 2021),
bladder (Long et al., 2020), and renal (Long et al., 2020) cancers. Upregulation of PUF60
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is associated with increased transcription of telomerase reverse transcriptase (Long et al.,
2020) and to overall tumor progression and malignancy (Long et al., 2020).
Zinc finger protein 33B (ZNF33B). Zinc finger domains are among some of the
most abundant types of proteins and have a broad range of functions including regulation
of transcription, DNA repair, and ubiquitin-mediated protein degradation among others
(Cassandri et al., 2017). ZNF33B has been found to be differentially expressed within the
cumulus cells of unstimulated humans (de los Santos et al., 2012). In mammalian
oocytes, zinc and other transition metals, have been implicated as important signal
transductors during meiosis (Kim et al., 2010; Schaefer-Ramadan et al., 2018). In mice
oocytes, it has been found that the overall zinc content increases by more than 50%
during meiosis and zinc insufficiency results in the failure of oocyte maturation
(Bernhardt et al., 2011). Zinc finger proteins have high expression in the testis,
particularly germ cells, and insufficiency results in infertility (Zhou et al., 2010).
However, the role of ZNF33B in these pathways is not fully understood.
Cell Adhesion.
Thrombospondin 1.

Thbs1 has limited elucidated function in the testis. In fetal

rats exposed to dibutyl phthalate, a known endocrine disruptor (Källsten et al., 2022),
Thbs1 was found to be significantly increased within peritubular myoid cells (Johnson et
al., 2007). Thbs1 is known to play a more defined role within the ovary, particularly
regarding follicular angiogenesis and ovulation (Osz et al., 2014). In cynomolgus
macaque, a species of Old-World monkey, treated with anti-Thbs1 antibody injected into
pre-ovulatory follicles had reduced follicle rupture and oocyte release (Bender et al.,
2019). These same follicles also showed a reduction in granulosa cell expansion and
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capillary formation (Bender et al., 2019) when compared to Ig-G control follicles. This
supports other observations wherein thrombospondins are associated with granulosa cell
proliferation and reduced vascularity (Osz et al., 2014), increased granulosa apoptosis
and follicular atresia (Thomas et al., 2008). It is believed that Thbs1 may also serve as a
component to follicular development and follicular selection (Greenway et al., 2005;
Greenway et al., 2007). Thbs1 has also been shown to act as a key player in luteolysis
following administration of PGF2α by activating apoptosis via caspase-3 and TGFB1
(Farberov et al., 2019).
Contactin 1.

The CNTN1 gene encodes for a glycosylphosphatidylinositol

(GPI)-anchored protein neuronal membrane protein associated with cell adhesion and
implicated in the development of axon connections (Berglund and Ranscht, 1994).
Currently CNTN1 does not have any known role in the testis or the ovary. CNTN1 has
been shown to be upregulated during synaptic formation (Brusés et al., 2010) as well as
supporting neuron plasticity during long-term depression of the hippocampus (Murai et
al., 2002). Contactin proteins are also found to be strongly correlated with oncogenic
progression and long-term prognosis (Gu et al., 2020). Increased mRNA expression of
CNTN1 has been identified in colorectal (Li et al., 2021), thyroid (Shi et al., 2015),
stomach (Liu et al., 2014), prostate (Gu et al., 2021; Yan et al., 2016), ovarian (Han et al.,
2021), and breast cancers (Chen et al., 2018). Moreover, in cancer cases in which
CNTN1 expression is altered it is heavily associated with increased invasion of malignant
cells into the lymph system and metastasis (Liang et al., 2020).
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Ubiquitination.
Ubiquitin conjugating enzyme E2 W.

While the process of ubiquitination

typically occurs at the C-terminus of substrates, UBE2W is currently the only known
mammalian ubiquinating enzyme that conjugates the N-terminus (Scaglione et al., 2015).
Substrates with N-terminal ubiquitination have been indicated as targets for degredation
such as viral protiens, TFs, and cell cycle regulators (Cienchanover and Ben-Saadon,
2004). Use of UBE2W knockout mice to evaluate the role of this enzyme found that
knockouts had higher instances of early postnatal lethality and altered maturation of the
epidermis (Wang et al., 2016). UBE2W has been found to have a broad expression across
tissue types with high expression of the enzyme localized to the thymus (Wang et al.,
2016) testis in mice (Zhang et al., 2008) with the highest concentrations between 2 and
10 weeks of age (Lei et al., 2020). Data from UBE2W knockout mice correlate with these
localization findings as the thymus and testis in these animals had significant decreases in
weight compared to wild type mice (Wang et al., 2016). Additionally, IHC experiments
also found that, within the testis, UBE2W is primarily observed within the cytoplasm of
Leydig and spermatogenic cells (Wang et al., 2016) and loss of UBE2W correlates with
hypospermatogenesis (Lei et al.,2020). Flow cytometry and signaling pathway analysis
found that spermatogenic cells deficient in UBE2W had increased rates of apoptosis and
increased caspase 6 and caspase 9 activity (Lei et al., 2020). Reduction of UBE2W, along
with other ubiquitination genes, was found within patients expressing a missense
mutation of a testicular RNA helicase (GRTH/DDX25) and a non-obstructive
azoospermia phenotype (Kavarthapu et al., 2020)
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Ubiquitin specific peptidase 42.

USP42 is a novel enzyme that is involved in

the deubiquitylation of substrates, which are involved in critical pathways that are
frequently dysregulated in cancer cells such as apoptosis and cell growth (Pfoh et al.,
2015). USP42 is a known to target the tumor suppressor, gene p53, and is co-localized
with Pol II and is thought to act as a gene regulator by deubiquitylating histones (Hock et
al., 2014). USP42 has also been identified to be expressed primarily in lung, brain,
thymus, and testis tissue of mice during embryonic development (Kim et al., 2007).
Northern blot analysis also found that expression of USP42 increases rapidly 2 weeks
after birth and remained high through the round spermatid stage, which indicates a role in
germ cell development and spermatogenesis (Kim et al., 2007).
Mitochondrial Function.
LOC 100524239.

This gene codes for the subunit 10 of cytochrome b-c1

complex, which is also known as Complex III of the electron transport chain (Chandel,
2010). Complex III plays a critical role in the generation of ATP via the generation
reactive oxygen species (ROS; Chandel, 2010) and maintains the proton gradient by
pumping protons into both the intermembrane space (IMS) and the mitochondrial matrix
(Mueller et al., 2004). Mutations in genes relating to complex III typically result in
exercise intolerance (DiMauro et al., 1985; Dumoulin et al., 1996) although deficiency
can lead to fatal phenotypes such as GRACILE and Björnstad syndromes (Salviati et al.,
2017; Guo et al., 2022; Falco et al., 2017).
Immune Response.
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Family with sequence similarity 89 member A.

FAM89A is a protein that

does not have a fully described function, although it is found to be expressed
differentially in human tissues following interleukin exposure and some pathologies (e.g.
atherosclerosis; Della-Morte et al., 2014; Gómez-Carballa et al., 2019). The homologous
protein found in rats also plays important roles in normal eye function and disease
(Ahmed et al., 2004) taken together these findings would suggest that FAM89A is
involved in immune pathways. FAM89A has been found to have expression within the
prostate, liver, kidney, and ovary (Pavlicev et al., 2015) although highest expression is
found within adipose and placental tissue (Fagerberg et al., 2014; Supplementary Index).
Lipid Metabolism.
Abhydrolase domain containing 18. This domain is included in the alpha/beta
hydrolase superfamily, which are involved in catalyzing lipid metabolism. While this
particular domain has limited characterization, it has been found that Asian populations
that have low levels of Alu repeats within the protein (Osenberg et al., 2010) are at
increased risk for hepatocellular carcinomas (Clifford et al., 2010). Pigs that have high
expression of this gene also present with extremely low fatty acid composition within
skeletal muscle, likely due to the expression of this gene in muscle (Puig-Oliveras et al.,
2014).
Protein Binding.
MORN repeat-containing protein 4. MORN4 is a member of the membrane
occupation and recognition nexus (MORN) motifs. MORN4 and its ortholog, found in
Drosophilia have been determined to be part of the binding partner/cargo of class III
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myosins and are highly conserved in evolution (Mecklenberg et al., 2015). This motif has
been shown to co-localize and bind with very high affinity to Myo3A (Le et al., 2019), a
steriocilia protein motor domain, which is associated with hearing loss (Lelli et al., 2016;
Dantas et al., 2018). MORN4 is also known to facilitate actin-based structures
(Mecklenberg et al., 2015) and to promote aconal degeneration following toxic,
metabolic, or traumatic insults to the nervous system (Bhattacharya et al., 2012). While
MORN4 presents new possibilities for therapeutic targets for neuropathies and neurotoxic
side effects from chemotherapy, little else is known about the biological role this motif
plays (Bhattacharya et al., 2012)
Novel and uncharacterized genes.
LOC110256684.

This gene, which currently remains unnamed and

uncharacterized, is believed to form a non-coding RNA transcript. It has also been
determined that this particular gene is downregulated in the livers of genetically diabetic
swine model (MIDY; Backman et al., 2019) although its function is still unknown.
MSTRG.8674. This sequence is an uncharacterized novel gene for a long noncoding RNA. In LPS challenged ileal mucosal tissue of 35-day-old weaned piglets,
MSTRG.8674 was found to be significantly elevated 3 hours post treatment compared to
controls (Guo et al., 2019). It is hypothesized that this gene may play a role in antiinflammatory response pathways but this has yet to be confirmed.
Of the 24 DEGs identified between the knockdown and control lines, 6 of them
(MSTRG.22278, MSTRG.22711, MSTRG.22055, MSTRG.22294, MSTRG.24229, and
LOC102162978) have no current publications of putative functions.
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The present study provides a description of the testicular transcriptome profiles of
GnRHR-II knockdown boars in reference to their control littermates via RNA-Seq. This
is the first study, to the best of our knowledge, which offers a comprehensive analysis of
GnRHR-II in relation to other functional transcripts within the swine testis. Use of whole
transcriptome sequencing techniques we were able to quantify differentially expressed
genes between our knockdown and control lines. We mapped 81,209 transcripts and
identified 22,143 matching porcine genes within the testis transcriptome. Of these, we
determined that there were 24 differentially expressed genes between our lines, 18
previously annotated and 6 novel genes.
The results from comparative analysis of RNA sequencing between GnRHR-II
knockdown boars and their control littermates confirm our knockdown model but also
open paths of investigation to understand the role of GnRHR-II. In previous studies, we
determined that not only do our knockdown swine produce functional GnRHR-II
transcript but we also concluded that the boars LH independent testosterone production
(Desaulniers et al., 2015). We did not identify any genes involved in classical
steroidogenesis; via LH-mediated signaling which indicates that GnRHR-II knockdowns
does not down-regulate traditional synthesis. Most interestingly, among the DEGs we
identified EGR1 as significantly downregulated in the testis of knockdown boars.
Previously, we determined the presence of an EGR1 binding site within the promoter of
porcine GnRHR-II (Brauer et al., 2016) indicating that it acts as a transcriptional
regulator. We have also demonstrated previously that GnRHR-II KD boars produce fewer
sperm cells per ejaculation and have significantly fewer AI doses. Of the 24 DEGs we
identified in the GnRHR-II KD boars, 5 of them (FAM24A2-like, MSI2, GUCY1A3,
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UBE2W, USP42) have been directly linked to spermatogenesis regulation. While it is
possible that the reduction in spermatogenesis is the result of decreased testosterone
synthesis, the regulation of these genes by GnRH-II has not been explored. Another
potential target of interest is Thbs1, which has been shown to play a role in the rate of
ovulation in cynomolgus macaque (crab-eating macaque; Bender et al., 2019), a primate
species known to have both GnRH-II and GnRHR-II (Desaulniers et al., 2018). Our lab
has demonstrated that GnRHR-II knockdown gilts have reduced rates of ovulation
compared to control littermates (P=0.0123; unpublished data).
Also worth future investigations is the role of Musashi RNA binding protein 2
(MSI2) in GnRHR-II knockdown boars. MSI2 is an RNA binding protein that is
important in the establishment of pluripotency in germ cell development (Wubben et al.,
2012). This family of binding proteins is known to be critical for testicular germ cell
maintenance and deficiencies can be linked to reduced litter sizes and infertility in null
mice (de Andrés-Aguayo et al., 2011).
Here we have identified a small collection of genes impacted within our GnRHRII boars that highlight possible downstream targets of GnRHR-II regulation. These DEGs
provide not only potential targets for improvement of boar fertility they also offer insight
into the broader regulatory pathways under the control of GnRHR-II.
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Table 4. Median characteristics of expressed transcripts.

Novel lncRNA

Novel mRNA

Known
Transcripts

0.21*

0.20*

0.15

11.24*†

40.77*

29.19

Number of exons

3*†

10*

9

ORF length (aa)

108*†

346*

468

Expression
(log10(FPKM+1))
Length (kbp)

*

Wilcoxon rank-sum P-value < 0.05 compared to known transcripts

†

Wilcoxon rank-sum P-value < 0.05 compared to novel mRNA
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Figure 15. Computational sequence for identification of novel transcripts
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Figure 16. lncRNA classifications
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Figure 17. lncRNA overlap with NONCODE database
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Figure 18. Novel mRNA overlap with RefSeq
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Table 5. Differentially expressed genes (DEG) in transgenic boars compared to control
boars.
Gene ID1

Direction of the expression
difference in transgenic boars
compared to control boars2

P-value

GNRHR2

Downregulated

< 0.0003

EGR1

Downregulated

< 0.005

GUCY1A3

Downregulated

< 0.003

THBS1

Downregulated

< 0.04

CNTN1

Downregulated

< 0.04

FIBIN

Downregulated

< 0.04

PUF60

Downregulated

< 0.04

MSI2

Downregulated

< 0.05

LOC110256684

Downregulated

< 0.02

LOC106504199

Downregulated

< 0.004

MSTRG.8674

Downregulated

< 0.04

FAM89A

Upregulated

< 0.005

UBE2W

Upregulated

< 0.02

ABHD18

Upregulated

< 0.02

USP42

Upregulated

< 0.03

ZNF33B

Upregulated

< 0.04

MORN4

Upregulated

< 0.04

LOC100524239

Upregulated

< 0.003

LOC102162978

Upregulated

< 0.04

MSTRG.22294

Upregulated

< 0.009

MSTRG.24229

Upregulated

< 0.04

MSTRG.22278

Upregulated

< 0.0001

MSTRG.22711

Upregulated

< 0.0001

MSTRG.22055

Upregulated

< 0.002

1

Genes are ranked based on the significance (FDR-adjusted P-value)

2

Differential expression was analyzed in the transgenic boars compared to control boars. Up- and
downregulated genes had a greater and lesser expression, respectively, in transgenic boars
compared to control boars
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